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Abstract 
 
Entamoeba histolytica is an enteric protozoan parasite responsible for human amebiasis. 
According to the World Health Organization, 50 million people, especially in the tropical 
countries, suffer from this infection, resulting in estimated 100 thousand deaths annually. No 
effective vaccine has yet been developed, and only metronidazole and its derivatives are the 
drugs of choice for treatment. It has been demonstrated that metronidazole targets 
pyruvate:ferredoxin oxidoreductase, which is involved in acetyl CoA production in central 
energy metabolism. However, their low efficacy against asymptomatic cyst carriers, cases of 
treatment failure and emergence of resistance have been reported. Therefore, other rational 
targets need to be explored to develop new chemotherapeutics against amebiasis.  
Coenzyme A (CoA), as a cofactor involved in >100 metabolic reactions, is essential to 
the basic biochemistry of life. Here, I investigated the CoA biosynthetic pathway of Entamoeba 
histolytica. I identified four key enzymes involved in the CoA pathway: pantothenate kinase 
(PanK, EC 2.7.1.33), bifunctional phosphopantothenate-cysteine ligase/decarboxylase (PPCS-
PPCDC), phosphopantetheine adenylyltransferase (PPAT) and dephospho-CoA kinase (DPCK). 
Cytosolic enzyme PanK and DPCK, were selected for further biochemical, genetic, and 
phylogenetic characterization. The E. histolytica genome encodes single copy of PanK 
(EhPanK) and two DPCK isotypes (EhDPCK1 and EhDPCK2). Epigenetic gene silencing of 
PanK resulted in a significant reduction of PanK activity, intracellular CoA concentrations, and 
growth retardation in vitro, reinforcing the importance of this gene in E. histolytica. Similar to 
PanK, epigenetic gene silencing of EhDPCK1 and EhDPCK2 also caused significant reduction 
of DPCK activity, intracellular CoA concentrations, and also led to growth retardation in vitro. 
These results indicated importance of PanK, DPCK1 and DPCK2 for CoA synthesis and 
proliferation.  
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Metabolomics analysis using capillary electrophoresis-mass spectrometry showed that 
PanK gene silencing caused significant changes in metabolites such as overall increase in 
majority of upstream (down to pyruvate) intermediates of glycolysis and the pentose phosphate 
pathway, and decrease in acetyl CoA, xanthine, hypoxanthine, ATP, cyclic nucleotides, 
ornithine, and S-adenosyl-L-methionine. On the other hand, suppression of EhDPCK gene 
expression also caused decrease in the level of acetyl-CoA, and metabolites involved in amino 
acid, glycogen, hexosamine, nucleic acid metabolisms, chitin and polyamine biosynthesis. 
Phylogenetic analysis also supported the uniqueness of the amebic enzymes compared to the 
human counterpart. Its biochemical, evolutionary features, and physiological importance of 
EhPanK and EhDPCKs indicate that these enzymes represent the rational target for the 
development of anti-amebic agents. 
Furthermore, I screened the Kitasato Natural Products Library for inhibitors of 
recombinant EhPanK, and identified 14 such compounds. One compound demonstrated 
moderate inhibition of PanK activity and cell growth at a low concentrations, as well as 
differential toxicity towards E. histolytica and human cells. Moreover, I also screened Indonesia 
microbial extracts against both recombinant EhPanK and EhDPCKs. Approximately 0.3 % of 
extracts inhibited EhPanK, 2.6% specifically inhibited EhDPCK1, 3.7% specifically inhibited 
EhDPCK2 and 2.2% inhibited both EhDPCK1 and EhDPCK2 from around 3,000 extracts tested.  
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Chapter 1. General Introduction 
 
1.1.  Entamoeba histolytica causes amebiasis 
Entamoeba histolytica is the protozoan agent responsible for human amebiasis, an 
infectious disease causing dysentery and amebic liver abscesses, responsible for 100,000 deaths 
annually throughout the world. It represents the third most common parasitic cause of death, 
after malaria and schistosomiasis (Stanley, 2003; Ali and Nozaki, 2007; Ralston and Petri, 
2011). The elaborate pathogenesis of this parasite is well documented (Espinosa-Cantellano and 
Martínez-Palomo, 2000; Nozaki and Bhattacharya, 2015). Metronidazole has, for decades, been 
the most effective drug in the treatment of amebiasis despite its known side effects and low 
efficacy against asymptomatic cyst carriers. Moreover, resistance, virulence and host immune 
response to metronidazole treatment in amebiasis have been reported in some countries (Griffin, 
1973; Pittman and Pittmann, 1974; Johnson, 1993; Koch et al., 1997; Ali and Nozaki, 2007). 
The molecular target of metronidazole has been well described as a key metabolic enzyme, 
pyruvate:ferredoxin oxidoreductase, which is involved in acetyl CoA production from pyruvate 
as part of  central energy metabolism. Identification and characterization of novel drug targets 
unique to E. histolytica are therefore needed to design better therapeutics against amebiasis.  
1.2. Coenzyme A is an important cofactor  
Coenzyme A is an essential cofactor in all living organisms as an acyl group carrier and 
carbonyl-activating group involved in more than 100 cellular reactions (Begley et al., 2001); it is 
estimated to be a cofactor used in 9% of identified enzymatic reactions (Strauss, 2010). CoA 
biosynthesis is considered to be an essential and universal pathway of the majority of 
prokaryotes and eukaryotes (Leonardi et al., 2005b). In general, CoA participates in fatty acid 
metabolism, the tricarboxylic acid cycle and numerous other intermediary metabolic reactions 
(Abiko, 1975). CoA is synthesized from pantothenate (vitamin B5), cysteine, and ATP 
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(Jackowski, 1996; Leonardi et al., 2005b). Most eukaryotes are unable to synthesize pantothenic 
acid and thus rely on an external supply. 
CoA is synthesized from several enzymatic steps. A water-soluble vitamin B5 
(pantothenate acid) is used for CoA biosynthesis by serving the main precursor. First, 
pantothenate is phosphorylated to 4’-phosphopantothenate by pantothenate kinase. The second 
enzyme, phosphopantothenoylcysteine synthase and 4’-phosphopantothenoylcysteine 
decarboxylase, play an important role to condense 4’-phosphopantothenate and cysteine to form 
4’-phosphopantetheine. 4’-Phosphopantetheine is subsequently converted to dephospho-CoA by 
phosphopanthetheine adenylyltransferase and phosphorylated by dephospho-CoA kinase at the 
3’-OH to form CoA. This process is relatively conserved among organisms, both prokaryotic 
and eukaryotic. 
1.3. Gene silencing strategy to understand the essentiality of the particular gene in E. 
histolytica 
Because of the lack of the tool for the genetic manipulation in E. histolytica, several 
approaches based on RNA interference (RNAi) methods or gene silencing has been successfully 
developed (Morf et al., 2013; Zhang et al., 2011b). Gene silencing is the regulation of gene 
expression in the cell to prevent the expression of a specific gene. The silencing process is 
started by transfecting the truncated-nucleotides that constructed in a specific plasmid containing 
a drug resistance gene, such as geneticin, into trophozoites of E. histolytica. After drug selection 
towards the transfected-cell line, the level of silencing of the certain target gene could be 
evaluated. Other important parameters such as growth kinetics, mRNA level, corresponding 
enzymes activity and metabolites disturbance also could be investigated from gene-silenced 
strains. Based on this strategy, I can evaluate the essentiality of the particular gene in E. 
histolytica parasite indicated by cell survival or growth retardation and physiological changes.  
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1.4. Metabolomics analyses reveal the metabolites disturbance during gene silencing 
To observe the effect of gene silencing throughout cellular metabolites or pathway, I 
performed the metabolomics analyses. Metabolomics analyses are described as a comprehensive 
assessment of endogenous metabolites and attempts to systematically identify and quantify 
metabolites from a biological sample (Zhang et al., 2012). This analyses is also important and 
integrated part of “multi-omics” analysis (i.e. proteomics, transcriptomics and metagenomics).   
Metabolites are the end product of the cellular reaction and the snapshot of instantaneously of 
the cell physiology. Therefore, this method provides a better understanding of cellular biology.  
Many advantages will be obtained due to metabolomics analyses, such as sensitive and specific 
and for functional genomic has benefit to detect phenotypic caused by genetic manipulation, 
gene deletion or silencing. Moreover, these analyses are also used to predict the functional 
mechanism of unknown genes.   
 1.5. Enzymatic-based screening for rapid discovery of anti-amebic agent 
Another strategy to rapidly discover some anti-amebic agents, instead of conventional 
cell-based screening, is enzymatic-based screening. Enzymes continue to be a major drug target 
are one of the best choices for identifying initial active chemical compounds (Williams and 
Scott, 2009). Some criteria to propose enzymes as a novel target should be fulfilled, such as 
enzymes must essential in this parasite, no similarity or low homology compared to the human 
ortholog, enzyme stability and reproducible in the assay system (Acker and Auld, 2014). Some 
approaches to developing, validating, and troubleshooting assays system are also an important 
factor for the enzymatic-based screening. In this study, I proposed and developed the enzymatic 
screening system for pantothenate kinase and dephospho-CoA kinase in E. histolytica as targets 
to discover potential specific inhibitors.   
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 1.6. Research objectives 
The objectives of this research are to search a potential novel drug target from CoA 
pathway. Since no publication related to CoA pathway and its importance in E. histolytica, I also 
did analyze, confirm and characterize enzymes involved in CoA biosynthesis and evaluate their 
essentiality to this parasite. The second objective is to characterize biochemically the selected 
essential enzymes in CoA pathway. The third objective is to find potential inhibitors of essential 
enzymes.     In this study, I investigated PanK and DPCK from E. histolytica, the first and the 
last enzyme involved in CoA pathway, respectively. In order to understand their essentiality, I 
used epigenetic gene silencing strategy and observed the disturbance in genetic and phenotypic 
level such as mRNA expressions, enzyme activities, CoA concentrations and growth kinetics. To 
expand my understanding of the independent role of PanK and DPCK, I also did metabolomics 
analyses of these gene silencing strain. Further investigation was the biochemical 
characterization of these recombinant PanK DPCK1 and DPCK2. Using these enzymes, I 
developed assay system and screened compound library and microbial extracts to find potential 
inhibitors against E. histolytica.  
In this report, I presented my result study of Entamoeba PanK and DPCKs into two 
separated main Chapters. The first Chapter was “Characterization and validation of Entamoeba 
histolytica pantothenate kinase as a novel anti-amebic drug target”. Another Chapter was 
“Genetic, biochemical, and metabolomic analyses of DPCK involved in coenzyme A 
biosynthesis in the human enteric parasite Entamoeba histolytica”. I also included 27 figures and 
12 tables related to this study that distributed into two Chapters above.    
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Chapter 2. Characterization and validation of Entamoeba histolytica pantothenate kinase 
as a novel anti-amebic drug target 
 
2.1. Abstract 
Coenzyme A (CoA), as a cofactor involved in >100 metabolic reactions, is essential to the basic 
biochemistry of life. Here, I investigated the CoA biosynthetic pathway of Entamoeba 
histolytica (E. histolytica), an enteric protozoan parasite responsible for human amebiasis. I 
identified four key enzymes involved in the CoA pathway: pantothenate kinase (PanK, EC 
2.7.1.33), bifunctional phosphopantothenate-cysteine ligase/decarboxylase (PPCS-PPCDC), 
phosphopantetheine adenylyltransferase (PPAT) and dephospho-CoA kinase (DPCK). Cytosolic 
enzyme PanK, was selected for further biochemical, genetic, and phylogenetic characterization. 
Since E. histolytica PanK (EhPanK) is physiologically important and sufficiently divergent from 
its human orthologs, this enzyme represents an attractive target for development of novel anti-
amebic chemotherapies. Epigenetic gene silencing of PanK resulted in a significant reduction of 
PanK activity, intracellular CoA concentrations, and growth retardation in vitro, reinforcing the 
importance of this gene in E. histolytica. Furthermore, I screened the Kitasato Natural Products 
Library for inhibitors of recombinant EhPanK, and identified 14 such compounds.  
Approximately 4.2% from 3,000 microbial extracts also inhibited EhPanK.  One compound 
demonstrated moderate inhibition of PanK activity and cell growth at a low concentrations, as 
well as differential toxicity towards E. histolytica and human cells.  
2.2. Introduction 
CoA is important in all living organism including a human parasite, Entamoeba 
histolytica. As a cofactor, it is generated from several steps of enzymatic reaction initiated by 
pantothenate (Vitamin B5) as a precursor. Some organisms are able to de novo synthesize 
pantothenate, but some other organism, mostly eukaryote, lack ability to synthesize it and rely 
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on the external uptake.  Entamoeba histolytica is one of eukaryotes that provide intracellular 
pantothenate from host or culture medium.  Four genes encoding sequential pathway enzymes in 
this parasite were identified from amoebadb database (AmoebaDB, 
http://amoebadb.org/amoeba/): pantothenate kinase (EC 2.7.1.33, PanK), bifunctional 
phosphopantothenate-cysteine ligase/decarboxylase (EC 6.3.2.5/EC 4.1.1.36), 
phosphopantetheine adenylyltransferase (EC 2.7.7.3), and dephospho CoA kinase (EC 2.7.1.24). 
However, all of these genes are annotated as putative and no evidence for it’s in vitro expression.  
Pantothenate kinase (PanK), the first enzyme in CoA biosynthesis, is an important 
enzyme for phosphorylating of pantothenate to 4’-phosphopantothenate. There has been reported 
that PanK is essential to Plasmodium berghei (Srivastava et al., 2016), Mycobacterium 
tuberculosis (Awasthy et al., 2010) and Arabidopsis thaliana (Tilton et al., 2006).  Moreover, 
specific inhibitors of PanK in other organism, such as P. falciparum (Chiu et al., 2017; 
Macuamule et al., 2015) and M. tuberculosis (Reddy et al., 2014) have also been discovered. 
However, the essentiality of PanK in E. histolytica is needed to be investigated. Therefore, in 
this report, I showed a comprehensive experiment to evaluate the essentiality of PanK in E. 
histolytica using epigenetic gene silencing strategy.   
Here, I investigate the CoA biosynthetic pathway of E. histoltyica and further 
characterized one of these enzymes, pantothenate kinase (PanK, EC 2.7.1.33), with biochemical 
and reverse genetic approaches. Metabolite changes because of PanK gene silencing, especially 
related to CoA pathway were also investigated using these analyses. Moreover, I identified E. 
histolytica PanK inhibitors by screening the Kitasato Natural Products Library and microbial 
extracts against EhPanK recombinant enzyme. Taken together, I demonstrate that the CoA 
biosynthetic pathway, in general, and PanK, specifically, represents a rational and novel drug 
target against amebiasis.  
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2.3. Materials and methods 
2.3.1. Organisms, cultivation, and chemicals 
Trophozoites of E. histolytica clonal strains HM-1: IMSS cl 6 and G3 (Bracha et al., 
2006) were maintained axenically in Diamond’s BI-S-33 medium at 35.5oC as described 
previously (Diamond et al., 1978). Trophozoites were continuously maintained in mid-log phase 
after inoculation of one-thirtieth to one-twelfth of the total culture volume. Escherichia coli 
BL21 (DE3) strain was obtained from Invitrogen (Carlsbad, CA, USA). Magnesium-free ATP 
was procured from DiscoverX (Fremont, CA, USA). Ni2+-NTA agarose was procured from 
Novagen (Darmstadt, Germany). Lipofectamine and geneticin (G418) were procured from 
Invitrogen. Chemicals to evaluate metals in PanK activity assay were procured from Wako 
(Tokyo, Japan).  All other chemicals of analytical grade were procured from Sigma-Aldrich 
(Tokyo, Japan) unless otherwise stated. 
2.3.2. Production of PanK gene-silenced strain  
 In order to construct a plasmid for epigenetic gene silencing  of E. histolytica (Bracha 
et al., 2006; Zhang et al., 2011a) PanK (EhPanK), a fragment corresponding to a 430 bp 5’ open 
reading frame of EhPanK gene was amplified by PCR from cDNA using the following primer 
set (sense primer, 5’-CAGAGGCCTATGTCTCAACCATCCCATTCT-3’ and antisense primer, 
5’-AATGAGCTCTCTGAAGATTACCAATCCCATAAA-3’). These oligonucleotides 
contained StuI and SacI restriction sites (shown in bold). The amplified product was digested 
with StuI and SacI, and ligated into the StuI and SacI double digested psAP2-Gunma construct 
(Husain et al., 2011) to synthesize a EhPanK gene silencing plasmid. The G3 strain trophozoites 
were transformed with empty vector as a control and the silencing plasmid was transfected by 
liposome-mediated transfection as previously described (Nozaki et al., 1999). Transformants 
were initially selected in the presence of 1 μg/mL geneticin gradually increased to 10 μg/mL. 
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2.3.3. Reverse transcriptase PCR 
RNA was extracted from approximately 1 x 106 trophozoites of EhPanK gene silenced 
(PanK gs) and control transformant strains using TRIzol reagent (Ambion, Life Technologies) as 
previously described (Chomczynski and Mackey, 1995). DNase treatment was performed using 
DNase I (Invitrogen) to exclude genomic DNA. RNA quantity was determined by measuring the 
absorbance at 260 nm with a NanoDrop ND-1000 UV-Vis spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA). Approximately one μg total RNA was used for cDNA 
synthesis using First-Stand cDNA Synthesis (Superscript® III, Invitrogen) with reverse 
transcriptase and oligo (dT) primers according to manufacturer’s instructions. The cDNA 
product was diluted 10-fold and PCR reactions were carried out in 50 μL, using the primer pair 
(Sense primer, 5’-ATGTCTCAACCATCCCATTC-3’ and antisense primer, 5’-
TTACATTAGTTCTTCTTCATACTC-3’). The PCR conditions were: 98°C, 10 sec; 55°C, 1 
min; and 72°C, 1 min; 20-25 cycles. The PCR products obtained were resolved by agarose gel 
electrophoresis. 
2.3.4. Quantitative real time (qRT) PCR 
Relative levels of steady state mRNA of the following genes were measured using qRT-
PCR: PanK (EHI_183060), bifunctional phosphopantothenate-cysteine ligase/decarboxylase 
(PPCS-PPCDC, EHI_164490), phosphopantetheine adenylyltransferase (PPAT, EHI_006680), 
dephospho CoA kinase 1 and 2 (DPCK1, EHI_040840; and DPCK2, EHI_155780), and RNA 
polymerase II gene (EHI_056690) as a control. Each 20 µL reaction contained 10 µL 2X Fast 
SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA), 0.6 µL each of 10 μM  
sense and antisense primers, 5 µL 10x diluted cDNA, and nuclease free water. PCR was 
performed using the StepOne Plus Real-Time PCR System (Applied Biosystems, Foster City, 
CA, USA) with the following cycling conditions: enzyme activation at 95oC for 20 sec, followed 
by 40 cycles of denaturation at 95oC for 3 sec and annealing-extension at 60oC for 30 sec. All 
reactions were carried out in triplicate, including cDNA-minus controls. The amount of the 
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steady state mRNA of each target gene was determined by the ∆Ct method with RNA 
polymerase II as a reference gene (Livak and Schmittgen, 2001). The mRNA expression level of 
each gene in the transformant was expressed relative to that in the control transfected with 
psAP2.  
2.3.5. Production of whole lysates from E. histolytica trophozoites 
Approximately 1 x 106 trophozoites were harvested 48 hours after initiation of culture, 
and washed with 2% glucose in 1X phosphate buffer saline (PBS) three times. Cells were 
counted and resuspended in 500 µL homogenization buffer (50 mM Tris-HCl, pH 7.5, 250 mM 
sucrose, 50 mM NaCl) supplemented with 1 mM phenylmethyl sulfonyl fluoride (PMSF) and 
0.5 mg/mL E-64 (Peptide Institute, Osaka, Japan). Cells were disrupted mechanically by a 
Dounce homogenizer and kept on ice for 30 min with intermittent vortexing followed by 
centrifugation at 500 x g for 30 min at 4°C for removing the insoluble cellular debris. The 
supernatant, representing total cell lysate, was carefully collected. Protein concentrations were 
spectrophotometrically determined by the Bradford method using bovine serum albumin as a 
standard as previously described (Bradford, 1976). 
2.3.6. Enzyme assays and quantitation of CoA in cell lysates 
PanK and DPCK activities in the cell lysate were measured with coupled assays using 
ADP HunterTM Plus Assay kit (DiscoverX, US) according to the manufacturer’s instructions. 
Briefly, fluorescence intensities were continuously measured to estimate the formation of 
resorufin at 37°C by excitation at 530 nm and emission at 590 nm in a 25 µL reaction mixture 
[10 mM MgCl2, 15 mM HEPES, 20 mM NaCl, 1 mM EGTA, 0.02% tween 20, 0.1 mg/mL β-
globulin, 2 mM pantothenate or 2 mM dephospho CoA for PanK or DPCK, respectively, 0.1 
mM ATP, 2 µL of cell lysate (~5 µg protein)]. Kinetic data were estimated by curve fitting with 
the Michaelis–Menten equation using GraphPad Prism (GraphPad Software Inc., San Diego, 
USA). This experiment was repeated three times in triplicate with proteins isolated from two 
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independent extractions, and kinetic values are presented as the means ± S.E. for three 
independent kinetic assays.  
Concentrations of CoA in the cell lysate were measured using the CoA assay kit 
(BioVision, CA, USA) according to manufacturer’s instructions. CoA at 0.05–1 nmole was used 
to produce a standard curve to determine the amounts of CoA in lysates.  Experiment were 
conducted in triplicate, and repeated three times on three different days. 
2.3.7. Monitoring of growth kinetics 
Trophozoite cultures were continuously maintained in mid-log phase as described 
previously, and placed on ice for 5 min to detach cells from the glass surface.  Cells were 
collected by centrifugation at 500 ×g for 5 min at room temperature. After discarding the spent 
medium, the pellet was re-suspended in 1 mL of BI-S-33 medium. Cell densities were estimated 
on a haemocytometer. Approximately 10,000 trophozoites were inoculated in 6 mL fresh BI-S-
33 medium. Cultures were examined every 24 hour for 5 days.  
2.3.8. Genome-wide survey of enzymes involved in CoA biosynthesis in the E. histolytica 
genome  
Putative genes encoding PanK, PPCS-PPCDC, PPAT, and DPCK were identified in the 
genome of HM-1:IMSS in the E. histolytica genome database (AmoebaDB, 
http://amoebadb.org/amoeba/) using the blastp online search tool (protein-protein BLAST). 
Human or bacterial orthologs (Human PanK1α/ NP_683878.1, E. coli bifunctional CoaBC/ 
WP_089667520.1, Human bifunctional COASY/ AAL50813.1) retrieved from non-redundant 
protein sequences (nr) database of National Center for Biotechnology Information (NCBI, 
http://www.ncbi.nlm.nih.gov/) were used as query sequences.  Pathway analysis was conducted 
using Kyoto Encyclopedia of Genes and Genomes database (KEGG, 
https://www.genome.jp/kegg). The steady state mRNA level of each gene in the trophozoite 
stage was examined using the previous array data as an independent experiment in both HM1: 
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IMSS cl6 (Penuliar et al., 2012, 2015) and G3 strains (Nakada-Tsukui et al., 2012; Furukawa et 
al., 2012, 2013). Then using Entamoeba invadens orthologs, I compared the mRNA expression 
levels of these genes during various timepoints during the encystation stage (De Cádiz et al., 
2013). 
2.3.9. Phylogenetic analysis of PanK  
Putative orthologs of PanK from a variety of organisms were retrieved by blastp search 
of non-redundant protein sequences (nr) database of National Center for Biotechnology 
Information (NCBI, http://www.ncbi.nlm.nih.gov/) using the EhPanK sequence 
(XP_001913460) as a query. To comprehensively retrieve all orthologs from representative 
organisms in variety of major taxa, I carried out blastp search against each taxonomic group as 
shown in Table S1. In each blastp analysis, a list of selected sequences was made with an E-
value less than 1 x 10-10 in pairwise alignments with EhPanK. Based on the lists for all 
taxonomic groups in Table S1, I selected 81 sequences as a final data set. The Muscle program 
(Edgar, 2004) in SeaView software package version 4.6.1 (Gouy et al., 2010) was used for 
sequence alignment. Then 145 unambiguously aligned positions were selected by manual 
inspection and used for phylogenetic analyses.  
The phylogenic data matrices were subjected to analysis with the IQTREE program 
(Nguyen et al., 2015) to select appropriate models for amino acid sequence evolution. The LG + 
4 model was found to be the best for analysis. Maximum likelihood (ML) analysis 
implemented in the RAxML program version 7.2.6 (Stamatakis, 2006) was used to infer the ML 
tree by applying LG + 4 model. In bootstrap analysis, heuristic tree search was performed with 
a rapid bootstrap algorithm option (-f) for 100 bootstrap replicates. Bootstrap proportion (BP) 
values greater than 50 were indicated on the corresponding internal branches of the ML tree 
drawn with FigTree program Version 1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/). 
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2.3.10. Production of E. histolytica transformant line to express Myc-tagged PanK 
The EhPanK gene was amplified from cDNA using Ex Taq DNA polymerase (Takara) 
using the following primer set (sense primer, 5’- GCCCCGGGATGTCTCAACCATCCCATTC 
-3’ and antisense, 5’- GCCTCGAG TTACATTAGTTCTTCTTCATACTC-3’), restriction sites 
are indicated in bold. An amplified fragment was ligated into SmaI and XhoI double digested 
pEhEx-Myc expression vector (Nakada-Tsukui et al., 2012) to produce pEhExMyc-PanK. The 
plasmid was introduced into trophozoites of E. histolytica HM-1:IMSS cl6 (Diamond et al., 
1978) by liposome mediated transfection (Nozaki et al., 1999). Transformants were selected and 
maintained as described previously. 
2.3.11. Cell fractionation and immunoblot analysis  
Trophozoites of the amoeba transformant expressing Myc-EhPanK and the mock 
transformant, transfected with pEhEx-Myc, were washed three times with PBS containing 2% 
glucose. After resuspension in homogenization buffer (50 mM Tris-HCl, pH 7.5, 250 mM 
sucrose, 50 mM NaCl and 0.5 mg/mL E-64 protease inhibitor), cells were disrupted 
mechanically by a Dounce homogenizer on ice, centrifuged at 500 x g for 5 min, and the 
supernatant was collected to remove unbroken cells. The supernatant fraction was centrifuged at 
5,000 x g for 10 min to isolate pellet and supernatant fractions. The 5,000 x g supernatant 
fraction was further centrifuged at 100,000 x g for 60 min to produce a 100,000 x g supernatant 
and pellet fractions. The pellets at each step were further washed twice with homogenization 
buffer and re-centrifuged at 100,000 x g for 10 min to minimize carryover. Immunoblot analysis 
was performed using the fractions and anti-Myc mouse monoclonal antibody. Anti-CPBF1 
(cysteine protease binding family protein 1) and anti-CS1 (cysteine synthase 1) rabbit antisera 
were used as organelle membrane and cytosolic markers, respectively. 
15 
 
2.3.12. Production of EhPanK recombinant protein 
 Plasmid was constructed as previously described (Sambrook and Russell, 2001). DNA 
fragment was amplified from E. histolytica cDNA. Primers used were sense, 5’- 
GCCGGGATCCATGTCTCAACCATCCCATTC -3’ and antisense, 5’- GCCG 
GTCGACTTACATTAGTTCTTCTTCATACTC-3’. Bold letters indicate BamHI and SalI 
restriction sites. PCR was performed with primeSTAR HS DNA polymerase (Takara) and the 
following parameters: initial incubation at 98ºC for 30 sec; followed by the 30 cycles of 
denaturation at 98ºC for 10 sec; annealing at 55ºC for 30 sec; and elongation at 72ºC for 1 min; 
and a final extension at 72ºC for 7 min. The PCR fragment was digested with BamHI and SalI, 
purified with Wizard® SV gel and PCR clean up system (Promega). The fragment was cloned 
into BamHI and SalI double digested pCOLD1TM histidine-tag vector (Takara) to finally produce 
pCOLD1-EhPanK. The nucleotide sequence of the engineered plasmid was verified by 
sequencing. 
pCOLD1-EhPanK was introduced into E. coli  BL21(DE3) cells via heat shock at 42ºC 
for 1 min. E. coli BL21 (DE3) harboring pCOLD1-EhPanK was grown at 37ºC in 100 mL of 
Luria Bertani medium (Invitrogen) in the presence of 100 µg/mL ampicillin (Nacalai Tesque). 
The overnight culture was used to inoculate 500 mL of fresh medium, and the culture was 
further continued at 37ºC with shaking at 180 rpm. When A600 absorbance reached 0.8, then 0.5 
mM isopropyl β-D-thio galactopyranoside (IPTG) was added, and cultivation was continued for 
another 24 h at 15ºC. E. coli cells from the induced culture were harvested by centrifugation at 
5,000 x g for 20 min at 4ºC. The cell pellet was washed with PBS, pH 7.4, re-suspended in 20 
mL of the lysis buffer (50 mM Tris HCl, pH 8.0, 300 mM NaCl, and 10 mM imidazole) 
containing 0.1% Triton x 100 (v/v), 100 µg/mL lysozyme, and 1 mM PMSF, and incubated at 
room temperature for 30 min. Then the mixture was sonicated on ice and centrifuged at 25,000 x 
g for 15 min at 4ºC. The supernatant was mixed with 1.2 mL of 50% Ni2+-NTA His-bind slurry, 
incubated for 1 hour at 4ºC with mild shaking. The recombinant enzyme-bound resin in a 
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column was washed three times with buffer A (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, and 
0.1% Triton X-100, v/v) containing 10-50 mM of imidazole. Bound protein was eluted with 
buffer A containing 100-300 mM imidazole. After the integrity and the purity of recombinant 
protein were confirmed with 12% SDS-PAGE analysis, followed by Coomassie Brilliant Blue 
staining, the sample was dialyzed against a 300-fold volume of 50 mM Tris-HCl, 150 mM NaCl, 
pH 8.0 containing 10% glycerol (v/v) and the Complete Mini protease inhibitor cocktail (Roche, 
Mannheim, Germany) for 18 hours at 4oC. Pure enzyme was stored at -80ºC with 20% glycerol 
in small aliquots until use.  
2.3.13. Metabolome analysis of of PanK gene silencing strain 
Intracellular metabolites were extracted according to previously (Jeelani et al., 2012) 
with some modifications. In brief, the 1 x 107 E. histolytica DPCK1 and DPCK2 gene silencing 
cells were harvested after 72 h cultivation in BIS medium. Cells were centrifuged 3,000 rpm for 
5 min and washed twice with 5% mannitol.  To quench metabolic activity, the cells were 
immediately extracted with a solvent composed of cold methanol, distillated water, chloroform 
(methanol: water: chloroform = 2:1:2 (v/v/v)). Internal standards, 200 µM of 2- (N-morpholino) 
ethanesulfonic acid and methionine sulfone were added to every sample to ensure that 
experimental artifacts such as ion suppression did not lead to misinterpretation of metabolite 
levels. After 30 second sonication, vortex and centrifugation at 15,000 g at 4 oC for 15 min, 
supernatant were filtered through 5-kDa cutoff filter then re-centrifuged max speed at 4 oC for 2 
h. The filtrates were dried and preserved at 28 oC until capillary electrophoresis-mass 
spectrometry (CE-MS) analysis (Kimball and Rabinowitz, 2006). 
CE-MS was performed using an Agilent CE Capillary Electrophoresis System equipped 
with an air pressure pump, an Agilent 1100 series MSD mass spectrometer and an Agilent 1100 
series isocratic high performance liquid chromatography pump, a G1603A Agilent CE-MS 
adapter kit, and a G1607A Agilent CE-MS sprayer kit (Agilent Technologies). System control, 
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data acquisition, and MSD data evaluation were performed using G2201AA Agilent 
ChemStation software for CE-MSD. Anionic and cationic metabolites were analyzed. 
Anionic were coated in SMILE (+) capillary 50-µm inner diameter x 100-cm total length 
obtained from Nacalai Tesque (Kyoto, Japan). The electrolyte was 50 mM ammonium acetate 
solution (pH 8.5). Sample solution (~30 nL) was injected at 50 mbar for 30 s and a negative 
voltage of  30 kV. The capillary voltage was set at 3.5 kV for ESI-MS in the negative ion mode. 
Deprotonated [M-H] ions were monitored for anionic metabolites of interest (Soga et al., 2002). 
Cationic nucleotides compounds were carried out on a gas chromatograph capillary, 
polydimethylsiloxane (DB-1) (50-µm inner diameter x 100-cm total length) (Agilent 
Technologies). CE separation was using 50 mM ammonium acetate, pH 7.5 as the electrolyte. 
Sample solution (~3 nL) was injected at 50 mbar for 3 s, and a positive voltage of 30 kV was 
applied. All other conditions were the same as in the anionic metabolite analysis. The energy 
charge was calculated as an index of contents of high energy phosphatebonds. Energy charge is 
defined as one-half the number of anhydride-bound phosphates per adenylate,  using the values 
for ATP, ADP and AMP, as the following:  
EC = (ATP + 1⁄2ADP)/(AMP +ADP +ATP).  
For each experimental condition, three (control) and five (PanK gene silencing strain) 
independent biological replicates were made and for each biological replicate, two technical 
replicates were made. All data are shown as means ± S.D. for the indicated number of 
experiments. Statistical comparisons were made by Student’s t test.  
2.3.14. Screening of natural compounds for EhPanK inhibitors 
I screened 244 compounds from the Kitasato Natural Products Library for inhibition of 
EhPanK activity and also 3,000 microbial extracts. Initially, each compound and extract was 
dissolved in 50% DMSO and water at a final concentration of 1 mg/mL. Enzymatic reactions 
were carried out on a black 384-well microtiter plate with a 20 µL reaction mixture composed of 
19 μl enzyme mix (100 μM pantothenate, 100 μM ATP, 50 ng of EhPanK recombinant enzyme 
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in kinase buffer (see above) and 1 μl of the individual compounds (final concentration 50 µg/mL 
or 25-200 µM) and extract at 37ºC for 2 hours. After the kinase reaction, ADP was measured 
using ADP HunterTM Plus kinase assay kit as described previously. Inhibition values were 
measured in triplicate.  
Compounds that showed more than 50% inhibition at <400 µM and extracts that showed 
more than 90% inhibition were re-tested to confirm that they did not inhibit the enzyme in the 
coupled assay (pyruvate kinase and pyruvate oxidase) in ADP HunterTM Plus kinase assay kit. 
Inhibition of the enzymes used in the coupled assay was examined in the reaction mixture (10 
mM MgCl2, 15 mM HEPES, 20 mM NaCl, 1 mM EGTA, 0.02% tween 20, 0.1 mg/mL β-
globulin, 60 μM pantothenate, 50 μM ATP, 10-50 μM ADP, and  25-200 μM of selected active 
compounds). No significant change was observed in a range of ADP and inhibitor 
concentrations, suggesting no inhibition of coupled enzymes by the EhPanK inhibitors.  
Compounds that did not inhibit enzymes used in the coupled assay were selected as hits for 
further evaluation, including: dose response, determination of concentration needed for 50% 
inhibition (IC50) of PanK activity as well as both E. histolytica and human cell growth. Extracts 
that did not inhibit couple enzymes were re-tested for its stability in various pH (2.7 and 9) and 
pre-heated 60 oC for 60 min. Stable extract were selected and reproduced in larger scale culture 
(5 liter). Culture then filtered, mycelium obtained were extracted using methanol and dried by 
rotary evaporator. Extracts purification were conducted using open column silica F60.  
2.3.15. Measurement of Anti-Amebic Activity of EhPanK inhibitor compounds 
Approximately 1 × 104 trophozoites of E. histolytica clonal strain HM-1:IMSS cl6 in 200 
μl of BI-S-33 medium were dispensed into each well of a 96-well plate and incubated at 35.5ºC 
for 2 h. Medium was then removed and replaced with 200 μl of BI-S-33 medium that contained 
various concentrations of each compound. The final concentrations of test compounds are: 50 to 
600 μM for  cephaloridine, hygromycin A, erythromycin A, and fluorescamine; 5 to 200 μM for 
kasugamycin, gardimycin, rosamycin, streptomycin, tirandamycin A, neomycin, and teicoplanin; 
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0.1 to 10 μM for O-methylnanaomycin A, echinomycin, and trichostatin. The plate was 
incubated under anaerobic conditions at 35.5ºC for 48 h. After the medium was removed, 100 μl 
of pre-warmed Opti-MEM I (Life Technologies, Grand Islands, NY, USA) containing one tenth 
volume of WST-1 (Roche, Mannheim, Germany) was added. The viability of trophozoites was 
estimated by measuring absorbance at 450 nm by SpectraMax® Paradigm® (Molecular Devices, 
CA, USA). Metronidazole was used as positive control at final concentrations of 0.1 to 10 μM 
and 0.5% DMSO as negative control. Each assay was performed in triplicate. IC50 values were 
calculated by least squares curve fitting of the dose inhibition curves using GraphPad Prism 
(GraphPad Software Inc., San Diego, USA). 
2.3.16. Evaluation of Cytotoxicity against MRC-5 Cells 
Human fibroblast cells, MRC-5, were cultured on 96-well flat bottom plates at a density 
of 1.5 × 104 cells/well with 100 μl of MEM medium (Life Technologie) containing 10% fetal 
bovine serum (Hana-nesco Bio, Tokyo, Japan) and 1% penicillin streptomycin (Life 
Technologies). Cells were incubated at 37ºC with 5% CO2 for 48 h. Approximately 100 μl of 
MEM medium containing 5 μl of each compound dissolved in 50% DMSO in water were added 
to each well. After the plates were incubated for 48 h, approximately 10 μl of WST-8 (Dojindo, 
Kumamoto, Japan) was added to each well and the plate was incubated at 37ºC with 5% CO2 for 
2 h. The absorbance was measured at 450 nm by spectrophotometer (SH-9000Lab, Corona 
Electric, Ibaraki, Japan). Growth of MRC-5 cells was measured in duplicate. Staurosporine 
(Kitasato Natural Products Library) was used as a positive (cytotoxic) control in a concentration 
range of 0.5 pM to 0.1 nM. IC50 values were calculated as described previously. 
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2.4. Results 
2.4.1. Identification of four enzymes involved in CoA biosynthesis in E. histolytica 
I identified all putative genes involved in CoA biosynthesis in the reference genome of E. 
histolytica: HM-1:IMSS (Fig. 1). Corresponding to PanK, I detected a single putative PanK gene 
in each strain (e.g., EHI_183060 in HM-1:IMSS and EHI7A_012650 in HM-1:IMSS-A) in 
Amoeba Genomics Resources database, AmoebaDB (http://amoebadb.org). The nucleotide 
sequences of the genes in different strains are 100% identical. Therefore, E. histolytica seems to 
have only one PanK gene. 
The previous transcriptome data verified that all four genes are expressed at low to 
moderate levels (Fig. 2A). The level of mRNA expression relative to RNA polymerase for 
PanK, PPCS-PPCDC, PPAT, DPCK1, and DPCK2 in trophozoites of the E. histolytica clonal 
strain HM1: IMSS cl6 (Penuliar et al., 2015, 2012) and G3 ( Nakada-Tsukui et al., 2012; 
Furukawa et al., 2012, 2013) strain were 1.2-1.8, 0.5-0.6, 0.3-0.4, 0.04-0.05 and 0.3-0.4, 
respectively.  In Chapter 2, I described biochemical and genetic characterization of PanK. The 
previous transcriptomic analysis of E. invadens (De Cádiz et al., 2013), as a model for 
encystation (Donaldson et al., 1975; Kojimoto et al., 2001; Stanley, 2003; Chia et al., 2009), 
showed that genes encoding these four enzymes were expressed during encystation, but the 
expression profiles of individual enzymes largely differed (Fig. 2B). The expression profiles of 
PPCS-PPCDC and DPCK1 were quite peculiar with expression peaking at certain time points (2 
h and 24 h, respectively); this subject was, however, not investigated as part of this study. 
2.4.2. Features of EhPanK and its encoded protein 
The 1,219-bp E. histolytica PanK gene contains two small introns, and is predicted to 
encode a 403 a.a. polypeptide with a molecular mass of 45.2 kDa and a pI value of 5.2. EhPanK 
showed 99, 96, 83, and 70% sequence identity to PanK from E. nuttalli, E. dispar, E. 
moshkovskii, and E. invadens, respectively. In general, PanK is classified into three groups, type 
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I through III, as determined by primary sequence analysis and kinetic properties (Song and 
Jackowski, 1993; Rock et al., 2002; Yang et al., 2006). E. histolytica PanK is classified as PanK 
type II, and shows a low level (~ 35%) of positional identity to the A. thaliana and human 
orthologs, both of which also belong to type II (Fig. 3 and 4). When compared to human PanK, 
Entamoeba PanK shows highest similarity to human PanK4 (35%), whereas similarity to other 
human PanK isotypes (PanK1α, PanK1β, PanK2, and PanK3) is ~32%.  All amino acid residues 
were inferred to be involved in pantothenate and ATP catalysis and substrate binding include the 
typical ATP-binding motif have been reported in human PanK1 and PanK3 (Bum et al., 2007). 
Some conserved glycine residues in the ATP binding motif (Gly19 and Gly321 in human PanK3; 
Gly59 and Gly351 in E. histolytica) are indispensable for activity. Mutations of this amino acid 
have been demonstrated to abolish enzymatic activity because ATP is no longer able to properly 
bind (Bum et al., 2007). Furthermore, it is understood that phosphorylation is proceeded by an 
ordered sequential mechanism, with ATP binding preceding pantothenate binding (Leonardi et 
al., 2005a).   
2.4.3. Phylogenetic analysis of EhPanK  
I determined the phylogenetic relationship between 81 putative PanK orthologs collected 
from bacteria and eukaryotes (Fig. 4). The majority of eukaryotes possess the PanK gene. 
Mammals (Opisthokonta) and land plants (Viridiplantae) apparently possess twice or more two 
genes. For instance, four PanK genes were identified from Homo sapiens, PanK1α and PanK1β 
(Rock et al., 2002), PanK2 (annotated as a mitochondrial precursor protein) (Hörtnagel et al., 
2003; Kotzbauer et al., 2005), and PanK3 (Zhang et al., 2005). Archaea and most bacterial 
groups do not possess PanK homologs that show similarity to EhPanK with the E-value less than 
10-10. PanK homologs were identified, however in firmicutes, specifically Bacilli. During 
sequence alignment, only the ‘fumble’ domain (PFAM:PFO03630) could be aligned among all 
81 sequences, although insertions and deletions were needed for proper alignment due to a high 
degree of divergence. PanKs from Euglenozoa have an ~1,000-a.a. long N-terminal extension, 
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which contains an exonuclease-endonuclease-phosphatase (EEP) domain in the 300 a.a.-long N-
terminal region and a 550 a.a.-long adenylate forming (AF) domain. Some of PanK from 
Viridiplantae have a 300 a.a.-long C-terminal extension, annotated as DUF89 (Domain of 
Unknown Function 89) (Huang et al., 2016). PanK from other organisms including the genus 
Entamoeba basically contain only a ‘fumble’ domain; neither the EEP/AF nor DUF89 domain is 
present in PanK from other organisms except that some possess an N-terminal extension that 
appears to be an organelle targeting sequence.  
Based on 145 aligned positions from the ‘fumble’ domain, an optimal ML tree was 
created with bootstrap proportion (BP) support values (Fig. 4). Eukaryotes and firmicutes were 
separated clearly with a 100% BP support value. The Eukaryota clade had monophylies of 
several taxonomic groups reconstructed, but BP values were generally low except for those of 
Viridiplantae monophyly (88%) and Haptophyceae monophyly (97%). Four Entamoeba species 
are monophyletic with 100% BP support, and the Entamoeba clade shares a sister group position 
to the clade of Euglenozoa. However, since BP support values for deep branching patterns were 
very low, monophly of Amoebozoa including the Entamoeba clade cannot be ruled out. 
Although this analysis could not precisely infer the phylogenetic position of the Entamoeba 
PanK, it is apparently of a eukaryotic origin.  
2.4.4. Expression and purification of recombinant PanK 
A soluble EhPanK recombinant protein with a 2.6 kDa histidine tag at the amino 
terminus was successfully produced using the pCOLD I E. coli expression system and purified 
to homogeneity (>95% as evaluated with Coommassie Brilliant Blue stained SDS-PAGE gel) 
(Fig. 5, Table 1). Immunoblot analysis of the purified recombinant protein using His-Tag 
antibody confirmed the absence of truncation (Fig. 5B). The molecular mass of the purified 
protein under reducing conditions was consistent with the predicted molecular mass 45.2 kDa 
excluding the histidine tag. The specific activity of the purified enzyme was estimated to be 1.5 
µmole/min/mg when assayed under the standard conditions described in the “Materials and 
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methods” section. EhPanK is robust and catalytically active in broad pH range with maximum 
activity obtained at pH 6 and 37ºC (Fig. 6A).  
2.4.5. Kinetic properties and phosphoryl donor specificities of EhPanK, and effects of 
metal ions on EhPanK 
Table 2 summarizes the apparent Km, Vmax, and Kcat values for EhPanK using 
pantothenate and ATP as substrates. EhPanK exhibited hyperbolic saturation kinetics when 
assayed over the substrate range of 4-256 μM for pantothenate in the presence of 25-100 μM 
ATP (Fig. 6B) and 1-100 μM ATP in the presence of 8-128 μM pantothenate (Fig. 6C). The 
apparent Km value for pantothenate at saturating ATP concentrations was 53.2 ± 7.1 μM, and the 
Km value for ATP at saturating pantothenate concentrations was 41.4 ± 3.9 μM.  
EhPanK utilized various nucleoside triphosphates, ATP, CTP, GTP, UTP, dATP, and 
polyphosphates, as well as deoxynucleotides as phosphoryl donors, with ATP being the best 
phosphate donor (Table 3). EhPanK showed an absolute requirement for a free bivalent metal 
cofactors, with Mg2+ as the preferred cation (Table 4).  
2.4.6. Regulation of EhPanK by CoA, acetyl CoA and malonyl CoA 
PanK from other organisms was reported to be negatively regulated by allosteric 
inhibition with CoA, acetyl CoA, and malonyl CoA (Calder et al., 1999; Takagi et al., 2010; 
Vallari et al., 1987). Similarly, EhPanK was also inhibited by CoA and its derivatives, although 
relatively higher concentrations were needed for inhibition compared with PanK from other 
organisms (Brand and Strauss, 2005; Calder et al., 1999) (Fig. 7). Double-reciprocal plots 
revealed the mechanisms of inhibition by CoA and malonyl CoA are competitive with ATP, 
while inhibition by CoA and malonyl CoA are uncompetitive or non-competitive with 
pantothenate, respectively. The mechanisms of inhibition by acetyl CoA were not clear, but 
seemed to be the mixed type with respect to ATP and pantothenate (Fig. 8). 
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2.4.7. Cellular localization of EhPanK 
To examine the localization of EhPanK, I performed fractionation and immunoblot 
analysis of PanK using E. histolytica transformant-expressing Myc-tagged EhPanK. I 
demonstrated that EhPanK is exclusively present in the 100,000 x g supernatant fraction 
corresponding the cytosol (Fig. 9). 
2.4.8. Effects of EhPanK gene silencing on growth, cellular CoA levels, and gene expression 
of the CoA biosynthetic pathway 
To investigate the physiological importance and essentiality of PanK in E. histolytica, I 
created and examined an E. histolytica strain where EhPanK was silenced by antisense small 
RNA-mediated transcriptional gene silencing (Mirelman et al., 2008); EhPanK gene expression 
was successfully silenced (Fig. 10A). The level of silencing was estimated to be approximately 
85% by qRT-PCR measurement. Interestingly, the steady-state transcript of the genes encoding 
other enzymes involved in CoA bioshynthesis were up-regulated 1.2 ± 0.03, 2.1 ± 0.2, 3 ± 0.1, 
and 5.2 ± 1.0-fold for PPCS-PPCDC, PPAT, DPCK1, and DPCK2, respectively (Fig. 10B).  
In order to determine whether the protein level also increased, I measured PanK and 
DPCK activity in cell lysates. PanK activity decreased by approximately 81% in the EhPanK-
silenced strain compared to the control. In contrast, DPCK activity increased 2.1 fold (Fig. 10C). 
CoA concentration decreased by approximately 40% in EhPanK-silenced strain compared to the 
control (Fig. 10D). Growth kinetic analysis also showed that in EhPanK-silenced strain showed 
remarkable growth retardation as the cell density of EhPanK-silenced strain decreased to 
approximately 30-52% of the control at 48-96 h, respectively (Fig 10E). Independent growth 
kinetic observation also showed dramatically retardation between 48-96 h incubation (Fig. 11).      
2.4.9. Metabolomic analysis of  EhPanK gene silencing 
 In order to understand the metabolic consequence of disturbance of CoA biosynthesis 
caused by repression of EhPanK gene expression in E. histolytica trophozoites, metabolomic 
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analysis was also performed using CE-MS. I detected and quantitated >120 metabolites, and 
identified 13 metabolites that significantly differed between EhPanK gene silenced and control 
transformants (p<0.05). I investigated the following metabolic pathways and specific metabolites 
in detail: carbon metabolism, nucleic acids, acetyl CoA, and related metabolites including citric 
acid, ornithine, and polyamines.  I also checked fatty acid metabolism, CoA-associated 
metabolism such as malonyl CoA, n-propionyl CoA and methylmalonyl CoA, but there was 
apparently no significant change.  The total amount of the glycolytic intermediates (represented 
by “Σ glycolysis”) and pentose phosphate pathway metabolites (“Σ PPP”) (Fig. 12) increased 1.4 
and 1.9-fold, respectively. Most of individual intermediate metabolites in glycolysis were 
increased (Fig. 12). Similarly, individual metabolites in the PPP were generally increased, while 
increase in D-sedoheptulose 7-phosphate being significant.  Nineteen out of thirty nucleic acids 
examined were depleted, among which hypoxanthine, xanthine, cAMP, cGMP, and cCTP were 
significant decreased (Fig. 13A).  
As described above, PanK gene silencing reduced the CoA level by 40%. Accordingly, 
acetyl CoA was also suppressed, while other CoA conjugates remained unchanged.  In addition, 
I found decrease in citrate, ornithine (also spermidine), and S-adenosyl-L-methionine (Fig. 13B). 
Ornithine and S-adenosyl-L-methionine are important intermediate metabolites for polyamine 
biosynthesis such as putrescine, spermidine, and spermine (Jeelani et al., 2012).  
2.4.10. Identification of EhPanK inhibitors from Kitasato Natural Products Library and 
microbial extracts 
Based on the significant biological role of EhPanK, inhibitors of this enzyme should be 
considered to possess properties needed for novel anti-amoebic agents. Therefore, I conducted 
enzyme-based screening of the Kitasato Natural Products Library composed of 244 structurally 
elucidated compounds using recombinant EhPanK to identify potential PanK inhibitors. I 
identified 14 compounds (Fig. 14) that demonstrated an IC50 value of <400 µM (Table 5, Fig. 
15). Among these compounds, Teicoplanin had the best inhibitory activity against EhPanK with 
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an IC50 value of 26.3 ± 2.6 µM. All EhPanK inhibitors also inhibited E. histolytica trophozoites 
although the IC50 values of most of the identified EhPanK inhibitors were high. Six compounds, 
O-methylnanaomycin A, Echinomycin, Tirandamycin A, Neomycin, Trichostatin, and 
Teicoplanin, showed the IC50 values of <20µM against E. histolytica trophozoites, but the IC50 
values of O-methylnanaomycin A, Echinomycin, Tirandamycin A, Neomycin, and Trichostatin 
against E. histolytica trophozoites were lower than their IC50 values against EhPanK activity, 
suggesting that the target of these compounds for growth inhibition are unlikely to be through 
PanK inhibition. In contrast, Teicoplanin demonstrated comparable IC50 values against PanK 
activity and E. histolytica growth (Table 6). 
 Beside compound library, I also screened 3,000 microbial extracts against EhPanK. 
There estimated 4.2 % from total extract inhibited EhPanK (Table 7). Approximately 0.3% (9 
extracts) from total extract could inhibit more than 90% EhPanK, then I categorized as hit 
extracts to be purified. Since compound purification from hit extracts still in progress, I excluded 
them (purification results) from this report. 
2.5. Discussion 
2.5.1. Identification of CoA biosynthesis as rational drug target 
CoA is an essential and ubiquitous cofactor functioning as an acyl carrier as well as a 
carbonyl activating group for many metabolic reactions. In the present study, I identified four 
enzymes that are involved in CoA synthesis in E. histolytica (Fig. 1), and characterized the first 
rate-limiting enzyme in this process, PanK. I have provided evidence for the pivotal role of this 
enzyme in cell proliferation by gene silencing.  
Since all genes involved in CoA biosynthesis are transcribed in all amoeba life cycle 
stages, this pathway is good target not only for killing the pathogenic trophozoites, but inhibiting 
stage conversion and thus amoeba transmission. The mechanism coordinating gene expression 
regulation among the five genes involved in E. histolytica CoA biosynthesis remains elusive. 
27 
 
However, based on the previous transcriptomic analysis of E. invadens, a related reptilian 
amoeba species that also causes an invasive disease and has been used as a model system for E. 
histolytica (Donaldson et al., 1975; Kojimoto et al., 2001; Chia et al., 2009) during encystation 
(De Cádiz et al., 2013), I found that PanK is transcribed in both trophozoite and encystation life 
cycle stages at comparable levels, suggesting that PanK is required in both stages.   
 A EhPanK gene-silenced strain was successfully established, after producing a strain in 
which EhPanK gene expression was ~85% repressed. Four failed attempts to create of such a 
cell line (data not shown) suggest the essentiality of this gene. The low levels of EhPanK in my 
experiment can keep the cells viable, consistent to previous publication in Mycobacterium 
tuberculosis PanK (Reddy et al., 2014).   Interestingly, EhPanK gene silencing resulted in the 
simultaneous transcriptional up-regulation of genes for downstream CoA pathway enzymes. 
Remarkably, such genes, DPCK1 and DPCK2, were up-regulated 3- and 5-fold, respectively. 
This observation is similar to that in experimentation with Plasmodium yoelii, where other genes 
in the CoA biosynthetic pathway were up-regulated when PanK2 gene was knocked out (Hart et 
al., 2016). Despite the apparent compensatory upregulation of downstream enzyme genes, CoA 
concentration was significantly reduced, which is most likely a direct cause of decreased ATP 
generation and retarded growth. 
In order to validate EhPanK as drug target, there should be notable biochemical, 
structural, and genetic differences in their human homologs. Such characteristics should, in 
theory, minimize toxic side effects of pharmacological inhibition of human enzymes via 
amebiasis chemotherapy. E. histolytica has one PanK enzyme whereas Homo sapiens has five 
PanK isoforms encoded by four genes. EhPanK is most closely related to human PanK4 with 
35% amino acid identity, but phylogenetic analyses suggests a distant relationship between 
EhPanK and its human counterparts.  
While PanK is indispensable for optimal growth of E. histolytica trophozoites, but in 
some eukaryotes, including human, PanK was shown non-essential. It has been demonstrated 
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that human cells have the ability to hydrolyze exogenous CoA to 4′-phosphopantetheine by 
ectonucleotide pyrophosphatase, and then incorporate 4′-phosphopantetheine and enzymatically 
convert it back to CoA by the bifunctional enzyme CoA synthase (Srinivasan et al., 2015). In 
Plasmodium, it was reported that PanK is nonessential in blood stage parasite development, but 
essential in the hepatic stage, as well as oocyst and sporozoite formation in the mosquito (Hart et 
al., 2016; Srivastava et al., 2016). In M. tuberculosis, CoaA was proven to be an essential 
enzyme (Awasthy et al., 2010), but was also shown in in vitro and in vivo studies to be a 
suboptimal target for antimycobacterial drug development because expression of CoaA gene 
needs to be repressed to obtain sufficient cidal effects by inhibitors (Reddy et al., 2014). On the 
other hand, CoaBC, a bifunctional enzyme in the CoA biosynthesis, has proven to be essential, 
but its suitability as drug target needs to be chemically validated in future (Evans et al., 2016). 
Inhibition of PanK in human cells may be tolerated, which also supports the premise that PanK 
is a reasonable chemotherapeutic target against pathogens for humans.  
2.5.2. Metabolic disturbance caused by PanK repression 
Gene silencing of EhPanK led to increase in the total glycolysis intermediates and PPP 
metabolites. Decrease in CoA and acetyl CoA concentrations likely caused the accumulation of 
upstream metabolites in glycolysis and PPP. Depletion of CoA and acetyl CoA probably led to 
oxidative stress, as suggested by my previous metabolomics experiment showing that the 
intermediates in the non-oxidative branch of PPP also increased upon oxidative stress (Husain et 
al., 2012). PPP is required in general for NADPH synthesis and fatty acid synthesis, nucleic acid 
synthesis, and cell survival (Patra and Hay, 2014; Tsouko et al., 2014). PPP activity is increased 
in cancer cells and also in response to oxidative stress (Przybytkowski and Averill-Bates, 1996). 
Thus, it is plausible that glycolysis also increases in E. histolytica to respond to the decrease of 
CoA and acetyl/acyl CoA, although underlying mechanisms remain to be elucidated. It has 
shown that PPP is not functional in E. histolytica, since this organism lacks glucose 6-phosphate 
dehydrogenase (G6PDH) and transaldolases (Loftus et al., 2005). It possesses an alternative 
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hexose-pentose interconversion pathway that does not require transaldolases, but depends on 
three enzymes: phosphofructokinase, transketolase, and aldolase (Susskind et al., 1982). 
Entamoeba histolytica generates NADPH via other alternative pathways, by which NADPH is 
produced from NADH by NAD kinase (Jeelani et al., 2013), or NADPH and NAD+ are produced 
from  NADH and NADP+ by pyridine nucleotide trans-hydrogenase using electrochemical 
proton gradient (Yousuf et al., 2010).  
Some cyclic nucleoside monophosphates (cAMP, cGMP and cCMP) were significantly 
decreased by EhPanK gene silencing.  They participate in many physiological responses 
(Bridges et al., 2005) such as protein-kinase cascades, down-regulation of drug responsiveness, 
and transmembrane signal transduction (Beavo and Brunton, 2002). They bind to protein kinase 
A, an enzyme family that plays an important role in glycogen, lipid, and sugar metabolism. 
Other nucleic acids including some purines, hypoxanthine and xanthine, were also significantly 
reduced by EhPanK gene silencing. These metabolites are involved in purine salvage pathway. 
In Plasmodium falciparum, enzymes in purine metabolic pathways are considered to be a 
promising novel drug target (Cassera et al., 2011).   
My metabolomics analysis also uncovered that suppression of PanK caused disturbance 
in polyamine metabolism, in particular decrease in ornithine, spermidine, and spermine, and 
increase in S-adenosyl-L-methionine. Polyamines have important functions in cell growth, 
biosynthesis of informing molecules, cell membrane stabilization, adaptation of the cell to ionic, 
osmotic, thermal and pH stress (Slocum et al., 1984; Tabor and Tabor, 1985). Ornithine is 
synthesized from acetyl CoA by several steps involving acetyl-, amino-transfer and 
(de)phosphorylation. It has been reported that ornithine is the essential precursor for polyamine 
synthesis in other parasites such as Leishmania (Roberts et al., 2016) and Trypanosoma (Taylor 
et al., 2008). Ornithine decarboxylase (ODC), a rate-limiting enzyme for polyamine 
biosynthesis, has been extensively studied as a drug target against parasitic infections and 
cancers (Bacchi and McCann, 1987; McCann et al., 1987; McCann and Pegg, 1992; Müller et 
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al., 2001). Polyamines are required in nucleic acid packaging and other function such as DNA 
replication, apoptosis, transcription, and translation (Ruan et al., 1994). Beside polyamines, 
citrate was also decreased together with upstream metabolites, CoA and acetyl CoA. Since E. 
histolytica lacks the entire tricarboxylic cycle including citrate synthase that converts acetyl CoA 
to citrate, and also electron transport chain and oxidative phosphorylation (McLaughlin and 
Aley, 1985; Reeves, 1985), the role of citrate is also poorly understood. 
2.5.3. Hit discovery of EhPanK inhibitors 
Historically, natural products, especially secondary metabolites, have provided various 
drugs against human diseases (Newman and Cragg, 2012). Several natural compounds from 
fungi and actinomycetes that inhibit cysteine synthase, an enzyme absent in humans and 
involved in de novo biosynthesis of L-cysteine have been discovered (Mori et al., 2015). In this 
study, I identified 14 inhibitors of EhPanK; half of the inhibitors have sugar moieties, and some 
of them are aminoglycosides.  
Teicoplanin showed moderate inhibitory activity with IC50 26.3 ± 2.6 µM and inhibition 
of E. histolytica trophozoite growth (IC50 15.1 ± 2.3 µM). Although Teicoplanin also 
demonstrated cytotoxicity to MRC-5 cells, preference towards E. histolytica cells was identified. 
Teicoplanin is a mixture of glycopeptide antibiotics used against Gram positive bacteria 
including methicillin-resistant Staphylococcus aureus, with a mechanism of action inhibiting 
bacterial cell wall synthesis. Teicoplanin consists of the glycopeptide core, two carbohydrates 
(mannose and N-acetylglucosamine), and a side chain. The components of teicoplanin are 
classified by their side chain length and conformation; the major components are A2-1 through 
A2-5.  
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2.6. Figures and Tables 
 
 
Fig. 1.  Coenzyme A biosynthetic pathway in E. histolytica. ID numbers of individual enzymes 
in AmoebaDB are also shown. PanK, pantothenate kinase; PPCS-PPCDC, bifunctional 
phosphopantothenoylcysteine synthetase and phosphopantothenoylcysteine decarboxylase; 
PPAT, phosphopantetheine adenylyltransferase; and DPCK, dephospho-CoA kinase. 
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Fig. 2. Relative mRNA expression level of all enzymes in CoA biosynthesis. A) Relative levels 
in trophozoites of the E. histolytica HM1: IMSS cl6 (Penuliar et al., 2012, 2015) and G3 
(Furukawa et al., 2013, 2012; Nakada-Tsukui et al., 2012) strain from array data. B) Relative 
levels in E. invadens encystation stage. Data was generated from previous publication (De Cádiz 
et al., 2013).  
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Fig. 3. Alignment of PanK protein sequences from E. histolytica and other organisms. The 
sequences were aligned using Muscle program (Edgar, 2004) in SeaView package version 4.6.1 
(Gouy et al., 2010). The species names and the NCBI accession numbers are as follows: E. 
histolytica (XP_001913460); Entamoeba nuttali (XP_008855986); Homo sapiens PanK4 
(NP_060686); Homo sapiens PanK3 (NP_078870); Arabidopsis thaliana (NP_001031768). 
Identical residues are denoted by asterisks (*). The glycine residue in the ATP binding sites are 
shown in white letter on with a black background. Serine, arginine, and alanine residues 
highlighted with black letters on a grey background indicate residues implicated for pantothenate 
binding sites. 
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Fig. 4. Phylogenetic tree of PanK from E. histolytica and other species. Optimal ML tree inferred by RAxML
program with LG +G4 model was shown. Unambiguously aligned 145 positions from 81 sequences were used for
the analysis.
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Fig. 5. Expression and purification of EhPanK in E. coli. A) Expression and purification of 
recombinant EhPanK. Protein samples at each step of purification were subjected to 12% SDS-
PAGE under reducing conditions, and the gel was stained with Coomassie Brilliant Blue. B) 
Immunoblot analysis of purified recombinant EhPanK using anti His-Tag antibody. 
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Fig. 6. Optimum pH and temperature (A) and initial rate plots (B, C) of EhPanK. A) Enzyme 
specific activity of recombinant EhPanK was measured at the various pHs and temperatures 
indicated in the figure. B) The velocity of EhPanK reaction at various pantothenate 
concentrations in the presence of 25, 50, or 100 µM ATP. C). The velocity of EhPanK reaction 
at various ATP concentrations in the presence of 8, 64, or 128 µM pantothenate. Assays were 
performed as described in Materials and methods, with 50 ng of EhPanK recombinant enzyme, 
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15 mM HEPES, 20 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 0.02% Tween-20, 0.1 mg/mL 
β−globulins. Assays for panes B and C were conducted at 37ºC at pH 6. Data are shown in mean 
± SEM of three replicates. 
 
 
Fig. 7. Effect of CoA, acetyl CoA, and malonyl CoA on the pantothenate kinase activities. 
Relative activities of EhPanK in the presence of various concentrations of inhibitors to those 
without inhibitors are shown. The assay was performed in 10 mM MgCl2, 15 mM HEPES, 20 
mM NaCl, 1 mM EGTA, 0.02% Tween-20, 0.1 mg/mL −globulins, 0.2 mM pantothenate, and 
100 μM ATP with various concentrations of CoA, acetyl CoA, or malonyl CoA at 37ºC at pH 6. 
The assays were carried out three times independently, and the results are shown as means ± 
SEM of triplicates.  
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Fig. 8.  Double-reciprocal plots of the recombinant EhPanK in the presence of CoA (A and B), 
malonyl CoA (C and D), or acetyl CoA (E and F). The enzymatic activities were determined 
with various concentrations of ATP and 0.2 mM pantothenate (A, C, and E) or various 
concentrations of  pantothenate and 100 µM ATP (B, D, and F), in the presence of three 
concentrations of inhibitors (0, 0.5, and 2 mM). Data are shown in means ± SEM of triplicate 
analyses.  
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Fig. 9. Cellular fractionation and immunoblot analysis of EhPanK. Trophozoites of Myc-
EhPanK expressing transformant (Myc-PanK) were fractionated as described in Materials in 
Methods, and subjected to immunoblot analysis using anti-Myc monoclonal antibody, anti-
CPBF1, and anti-CS1 polyclonal antisera. CPBF1 and CS1 serve as control of organelle and 
cytosolic proteins, respectively. Whole lysate of control strain transformed with empty vector 
was also subjected to analysis.  
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Fig. 10. Analyses of EhPanK gene silenced strain. A) RT-PCR analysis of EhPanK gene 
transcript from E. histolytica transformants. “psAP” indicates control strain transfected with 
psAP-2-Gunma empty vector, and “PanK gs” indicates EhPanK gene silenced strain. B) Relative 
levels of gene transcripts encoding all four enzymes involved in CoA biosynthesis by qRT-PCR 
analysis in psAP and Pan Kgs transformants. qRT-PCR data were normalized against RNA 
polymerase II, and are shown in percentage relative to the transcript level of each gene in psAP 
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control. C) PanK and DPCK activity in cell lysates of psAP and PanKgs transformants. D) CoA 
concentration in cell lysates. For B-D, data are shown in mean ± SEM of three biological 
replicates. Statistical comparison is made by Student’s t test (*P<0.05, **P<0.01). E) Growth 
kinetic of E. histolytica transformants during 96 h incubation in BI-S-33 medium. Data are 
shown in mean ± SEM of three replicates. Data from one representative experiment of three 
conducted independently are shown. Statistical comparison is made by Student’s t test (*P<0.05, 
**P<0.01).  
 
 
Fig. 11. Growth kinetic of E. histolytica transformants during 96 h incubation in BI-S-33 
medium from two other independent experiments (A and B). Data are shown in mean ± SEM of 
three replicates.  
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Fig. 12. PanK gene silencing promotes the increasing of glycolysis and pentose phosphate 
metabolites. Data show amounts of some metabolites in glycolysis and PPP. ΣPPP indicates total 
sum values of R-5-P, Ru-5-P and Sed-7P. Σglycolysis indicates total metabolites in glycolysis 
pathway from G-1-P to pyruvate.   Data are expressed as mean ± s.d. (nmol 10-6 cells) of three to 
five separate experiments. *P<0.05 versus controls (unpaired Student’s t-test). ND; not detected; 
G-6-P, glucose 6-phosphate; F-6-P, fructose-6-phosphate; F-1,6-BP, fructose 1,6-bisphosphate; 
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GA3P, glyceraldehyde 3-phosphate; DHAP, dihydroxyacetone phosphate; BPG, 
bisphosphoglycerate; 3-PG, 3-phosphoglycerate; 2-PG, 2-phosphoglycerate; PEP, 
phosphoenolpyruvate; AcCoA, Acetyl Co Enzyme A; CoA, Coenzyme A; 4-PP, 4’-
Phosphopantothenate;  6-PG, 6-phosphogluconate; Ru-5-P, ribulose-5-phosphate; R-5-P, ribose-
5-phosphate; Xu-5-P, xylulose-5-phosphate; Sed-7P, sedoheptulose-7-phosphate; Ery-4P, 
erythrose-4-phosphate. 
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Fig. 13. PanK gene silencing suppresses nucleic acids and polyamines biosynthesis. A, Some 
nucleic acids were depleted in PanK gene silencing strain. Data are expressed as mean ± S.D. 
(nmol 10-6 cells) of three to five separate experiments. *P<0.05 versus controls (unpaired 
Student’s t-test). B, Depletion of metabolites in ornithine and polyamines biosynthesis. Data 
show in mean ± s.d. (nmol 10-6 cells) of three to five separate experiments. Dashes lines indicate 
genes likely absent in the genome. *P<0.05 versus controls (unpaired Student’s t-test). 
Abbreviations are: ND, not detected; AdoMet, S-Adenosyl methionine; dAdoMet, 
Sadenosylmethioninamine; MAO, monoamine oxidase; AdoMDC, S-adenosylmethionine 
decarboxylase; SPDS, spermidine synthase; SPS, spermine synthase; GAD, glutamate 
decarboxylase. 
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Fig. 14. Structures of EhPanK inhibitors from compound library identified in this study. 
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Fig. 15. Dose-response data of inhibitors against EhPanK inhibitors. IC50 values were 
determined by dose-response-inhibition using GraphPad Prism (GraphPad Software Inc., San 
Diego, USA). Data are shown in mean of three replicates.  
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Table 1. Purification of recombinant E. histolytica pantothenate kinase. Enzyme activity was 
measured as described in Materials and methods. 
Sample Protein concentration 
(mg/ 500 mL culture) 
Total activity 
(μmole/min) 
Specific activity 
(μmole/min/mg) 
Yield 
(%) 
Purification 
(fold) 
Whole lysate 4.26 1.11 0.26 100 - 
Eluate  0.25 0.39 1.59 35.2 6.1 
 
Table 2. Kinetic parameters of E. histolytica pantothenate kinase 
Substrate Km 
(μM) 
Vmax 
(μmole/min/mg) 
Kcat 
(min-1) 
Kcat/Km 
(min-1μM-1) 
Pantothenate 53.2 ± 7.1 2.79 ± 0.1 126.8 ± 4.5 2.38 ± 0.08 
ATP 41.4 ± 3.9 2.84 ± 0.2 129.1 ± 9.2 3.11 ± 0.22 
Mean±SEM of three replicates are shown. 
 
Table 3. Phosphoryl donor specificity of E. histolytica pantothenate kinase  
Phosphoryl donora  Relative activity (%)  Phosphoryl donora  Relative activity (%)  
ATP 100.0 ± 4.1 CTP 1.4 ± 0.2 
GTP 78.8 ± 4.9 Metaphosphate ND 
dATP 19.3 ± 4.3 Hexametaphosphate ND 
Tripolyphosphate 16.9 ± 0.8 Trimetaphosphate ND 
UTP 16.6 ± 1.2 Glucose-6-phosphate ND 
Polyphosphate 16.2 ± 2.5 Phosphoenolpyruvate ND 
TTP 5.4 ± 1.9 None ND 
 
Assays were performed as described in Materials and methods, in the presence 15 mM HEPES, 20 mM NaCl, 10 
mM MgCl2, 1 mM EGTA, 0.02% Tween-20, 0.1 mg/mL β−globulins and 0.2 mM pantothenate. Reactions were 
conducted at 37ºC at pH 6. 
a The final concentration used was 100 µM.  
The activity is shown in percentage (%) relative to that toward ATP.  
ND, not detected. 
Mean±SEM of three replicates are shown. 
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Table 4. Effect of metal ions on the activity of E. histolytica pantothenate kinase  
Metala Relative activity (%) 
MgCl2 100.0 ± 0.0 
CuCl2 84.3 ± 4.7 
MnCl2 83.2 ± 2.0 
CoCl2 74.2 ± 6.1 
FeCl2 72.8 ± 1.7 
LiCl2 34.5 ± 1.8 
CaCl2 17.0 ± 3.0 
ZnCl2 3.9 ± 0.7 
NiCl2 ND 
NaCl ND 
KCl ND 
None ND 
 
Assays were performed as described in Materials and methods, in the presence of 100 mM ATP, 15 mM HEPES, 20 
mM NaCl, 1 mM EGTA, 0.02% Tween-20, 0.1 mg/mL β−globulins and 0.2 mM pantothenate. Reactions were 
conducted at 37oC at pH 6.0. 
a The cation final concentration used was 5 mM.  
The activity is shown in percentage (%) relative to that toward MgCl2. ND, not detected. 
Mean±SEM of three replicates are shown. 
 
Table 5. Inhibitory activities of EhPanK inhibitors from Kitasato Natural Products Library 
Compound IC50 (µM) 
Cephaloridine 
Kasugamycin 
Gardimycin 
Hygromycin A 
O-methylnanaomycin A 
Rosamycin 
Streptomycin 
Erythromycin A 
Echinomycin 
Tirandamycin A 
Neomycin 
Fluorescamine 
Trichostatin 
Teicoplanin  
229.9 ± 10.1 
254.1 ± 4.7 
  49.2 ± 4.8 
193.7 ± 17.8  
283.8 ± 28.7 
165.7 ± 2.0 
155.4 ± 10.1 
131.3 ± 6.0 
77.8 ± 4.4 
228.8 ± 3.4 
147.2 ± 6.8 
346.4 ± 14.7 
309.9 ± 14.9 
  26.3 ± 2.6 
Mean±SEM of three replicates are shown. 
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Table 6. In vitro anti-amebic activity and cytotoxicity against MRC-5 cells of EhPanK 
inhibitors. 
Compound 
IC50 (µM) 
E. histolytica 
trophozoite 
Normal human cell 
(MRC-5) 
Cephaloridine 
Kasugamycin 
Gardimycin 
Hygromycin A 
O-methylnanaomycin A 
Rosamycin 
Streptomycin 
Erythromycin A 
Echinomycin 
Tirandamycin A 
Neomycin 
Fluorescamine 
Trichostatin 
Teicoplanin  
Metronidazole 
245.78 ± 34.92 
66.16 ± 13.68 
34.40 ± 3.16 
142.22 ± 16.34 
1.68 ± 0.05 
56.34 ± 11.72 
77.53 ± 1.52 
155.88 ± 20.57 
0.26 ± 0.04 
13.71 ± 4.85 
10.58 ± 1.12 
167.90 ± 20.07 
0.29 ± 0.04 
15.08 ± 2.25 
0.66 ± 0.05 
48.20 ±  3.61  
87.10 ± 7.22 
>52.9 
>196 
18.98 ± 0.49 
34.40 ± 2.71 
>172 
>136 
<0.38 
143.88 ± 3.80 
>163 
287.77 ± 17.84 
2.62 ± 0.49 
>53.3 
>100 
Mean±SEM of three replicates are shown. 
 
Table 7. EhPanK inhibitor from compounds library and microbial extracts 
Origin Number of 
samples 
EhPanK inhibitor* 
   
Fungi 1,340 66 
Actinomycetes 1,660 62 
Total 3,000 128 
      4.2% 
*Inhibited >50% EhPanK. 
 
 
 
  
51 
 
Chapter 3. Genetic, biochemical, and metabolomic analyses of DPCK involved in coenzyme 
A biosynthesis in the human enteric parasite Entamoeba histolytica 
 
3.1. Abstract 
Coenzyme A (CoA) is an essential cofactor for numerous cellular reactions in all living 
organisms. In the protozoan parasite Entamoeba histolytica, CoA is synthesized in a pathway 
consisting of four enzymes with dephospho-CoA kinase (DPCK) catalyzing the last step. 
However, the metabolic and physiological roles of E. histolytica DPCK remain elusive. In this 
study, I took biochemical, reverse genetic, and metabolomic approaches to elucidate role of 
DPCK in E. histolytica. The E. histolytica genome encodes two DPCK isotypes (EhDPCK1 and 
EhDPCK2). Epigenetic gene silencing of EhDPCK1 and EhDPCK2 caused significant reduction 
of DPCK activity, intracellular CoA concentrations, and also led to growth retardation in vitro, 
suggesting importance of DPCK for CoA synthesis and proliferation.  Furthermore, 
metabolomic analysis showed that suppression of EhDPCK gene expression also caused 
decrease in the level of acetyl-CoA, and metabolites involved in amino acid, glycogen, 
hexosamine, nucleic acid metabolisms, chitin and polyamine biosynthesis. The kinetic properties 
of E. histolytica and human DPCK showed remarkable differences; e.g., the Km values of E. 
histolytica and human DPCK were 58-114 μM and 5.2 μM toward dephospho-CoA and 15-20 
μM and 192 μM for ATP, respectively. Phylogenetic analysis also supported the uniqueness of 
the amebic enzyme compared to the human counterpart. These biochemical, evolutionary 
features, and physiological importance of EhDPCKs indicate that DPCK represents the rational 
target for the development of anti-amebic agents. 
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3.2. Introduction 
Coenzyme A (CoA) is an essential cofactor as an acyl group carrier and carbonyl 
activating group (Baddiley et al., 1953) in metabolism that contributes to 9% out of 3,500 
cellular activities (www.brenda-enzymes.info/). CoA is synthesized by five to six enzymatic 
reactions with pantothenic acid (vitamin B5), L-cysteine, and purine/pyrimidine nucleotides as 
substrates (Genschel et al., 1999). Pantothenate is either produced de novo, as in bacteria, 
archaea, mammals, and plants (Begley et al., 2001; Chakauya et al., 2008; Spry et al., 2008), or 
alternatively, scavenged by uptake (Saliba et al., 1998; Spry et al., 2008). It was shown that the 
first and last steps, catalyzed by pantothenate kinase (PanK) and dephospho-CoA kinase (DPCK, 
EC 2.7.1.24) are rate limiting and allosterically regulated (Hart et al., 2017; Leonardi et al., 
2005b). Both enzymes utilize ATP as a phosphate donor and are essential in many organisms 
(Hart et al., 2017). 
In E. histolytica, it has been previously shown that repression of PanK gene causes defect 
in proliferation, and expression of DPCK genes was transcriptionally up-regulated by repression 
of PanK gene expression. This Chapter 2 reinforces the premise that the CoA biosynthetic 
pathway plays a pivotal role in trophozoite proliferation. While the first rate limiting and 
regulate enzyme was well characterized, the metabolic and physiological roles of the enzyme 
that catalyzes the last step of the pathway remain elusive. DPCK utilizes ATP to phosphorylate 
dephospho-CoA at the 3’-hydroxyl group of the ribose moiety to generate CoA. The E. 
histolytica genome apparently encodes two isotypes of DPCK. In the present study, I conducted 
biochemical characterization of recombinant enzymes. I also undertook reverse genetic and 
metabolomic approaches to elucidate the physiological importance of DPCK in this parasitic 
protist. 
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3.3. Materials and methods 
3.3.1. Organisms, cultivation, and chemicals 
 Trophozoites of the E. histolytica clonal strain HM-1: IMSS cl 6 and G3 strains (Bracha 
et al., 2006) were maintained axenically in Diamond’s BI-S-33 medium at 35.5oC as described 
previously (Diamond et al., 1978). Trophozoites were continuously maintained in mid-log phase 
after inoculation of one-thirtieth to one-twelfth of the total culture volume. Escherichia coli 
BL21 (DE3) strain was purchased from Invitrogen (Carlsbad, CA, USA). Lipofectamine and 
geneticin (G418) were also purchased from Invitrogen. Ni2+-NTA agarose was purchased from 
Novagen (Darmstadt, Germany). All other chemicals of analytical grade were purchased from 
Sigma-Aldrich (Tokyo, Japan) unless otherwise stated. 
3.3.2. Plasmid construction for recombinant EhDPCK1 and EhDPCK2 
Plasmids to express recombinant EhDPCK1 and 2 proteins were constructed according to 
the procedures previously described (Sambrook and Russell, 2001). DNA fragments 
corresponding to the protein coding region of EhDPCK1 and EhDPCK2 gene were amplified 
from E. histolytica cDNA, using oligonucleotide primers: 
EhDPCK1 sense (5’- GCCGGGATCCATGAAAAAGATATTTGTTATTGGT -3’), antisense 
(5’- GCCGGTCGACTTAAAATTTATTTTCATTGAAGTCAA -3’) and EhDPCK2 sense (5’- 
GCCGGGATCCATGGTATTTGTTATTGGTATC -3’), antisense (5’- 
GCCGGTCGACTTAGTTTAAAGTAATTTTTAATTGTT -3’). Underline letters indicate 
BamHI and SalI restriction sites. PCR was performed with primeSTAR HS DNA polymerase 
(Takara) and the following parameters: an initial incubation at 98ºC for 30 sec; followed by the 
30 cycles of denaturation at 98ºC for 10 sec; annealing at 55ºC for 30 sec; and elongation at 
72ºC for 1 min; and a final extension at 72ºC for 7 min. The PCR fragments were digested with 
BamHI and SalI, purified with Wizard® SV gel and PCR clean-up system (Promega). The 
fragments were cloned into BamHI and SalI double digested pCOLD1TM histidine-tag vector 
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(Takara) to finally produce pCOLD1-EhDPCK1 and pCOLD1-EhDPCK2. The nucleotide 
sequences of the engineered plasmid were verified by sequencing. 
3.3.3. Production and purification of recombinant EhDPCK1 and EhDPCK2 
pCOLD1-EhDPCK1 and pCOLD1-EhDPCK2 were introduced into E. coli  BL21(DE3) 
cells by heat shock at 42ºC for 1 min. E. coli BL21 (DE3) harboring pCOLD1-EhDPCK1 and 
pCOLD1-EhDPCK2  were grown at 37ºC in 100 mL of Luria Bertani medium (Invitrogen) in 
the presence of 100 μg/mL ampicillin (Nacalai Tesque). The overnight culture was used to 
inoculate 500 mL of fresh medium, and the culture was further continued at 37ºC with shaking at 
180 rpm. When A600 reached 0.8, 0.5 mM isopropyl β-D-thio galactopyranoside (IPTG) was 
added, and cultivation was continued for another 24 h at 15ºC. E. coli cells from the induced 
culture were harvested by centrifugation at 5,000 x g for 20 min at 4ºC. The cell pellet was 
washed with PBS, pH 7.4, re-suspended in 20 mL of the lysis buffer (50 mM Tris HCl, pH 8.0, 
300 mM NaCl, and 10 mM imidazole) containing 0.1% Triton X-100 (v/v), 100 μg/mL 
lysozyme, and 1 mM PMSF, and incubated at room temperature for 30 min, sonicated on ice and 
centrifuged at 25,000 x g for 15 min at 4ºC. The supernatant was mixed with 1.2 mL of 50% 
Ni2+-NTA His-bind slurry, incubated for 1 hour at 4ºC with mild shaking. The recombinant 
enzyme-bound resin in a column was washed three times with buffer A (50 mM Tris-HCl, pH 
8.0, 300 mM NaCl, and 0.1% Triton X-100, v/v) containing 10-50 mM of imidazole. Bound 
protein was eluted with buffer A containing 100-300 mM imidazole. After the integrity and the 
purity of recombinant protein were confirmed with 12% SDS-PAGE analysis, followed by CBB 
staining, the sample was dialyzed against a 300-fold volume of 50 mM Tris-HCl, 150 mM NaCl, 
pH 8.0 containing 10% glycerol (v/v) and the Complete Mini protease inhibitor cocktail (Roche, 
Mannheim, Germany) for 18 h at 4oC.  Pure enzyme was stored at -80ºC with 20% glycerol in 
small aliquots until use. 
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3.3.4. Enzymes assay 
DPCK activities of recombinant proteins and those in lysates were measured by a 
coupling assay using ADP HunterTM Plus Assay kit (DiscoverX, US) according to the 
manufacturer’s instructions. Enzymatic assays were carried out using 50 ng of recombinant 
EhDPCK1 or EhDPCK2 using 4-256 μM for dephospho-CoA, 5-100 μM ATP. The kinetic 
parameters were estimated using the non-linear regression function obtained from the GraphPad 
Prism software (GraphPad Software Inc., San Diego, CA). The experiments were repeated three 
times in triplicate using protein preparations from three independent extractions, and kinetic 
values are presented as the means ± S.E.  
3.3.5. Production of EhDPCK1 and EhDPCK2 gene-silenced strains 
Small antisense RNA-mediated transcriptomic gene silencing  (Bracha et al., 2006; 
Zhang et al., 2011a) was used to repress gene expression of EhDPCK1 and EhDPCK2 genes 
with some modifications. Briefly, fragments corresponding to a 400 bp long of the open reading 
frame were amplified by PCR from cDNA using specific of oligonucleotides as follow: 
EhDPCK1 sense (5’-CAGAGGCCTATGAAAAAGATATTTGTTATTGGTAT-3’), antisense 
(5’- AATGAGCTCCAATGGCAATTTCAGGTGA-3’) and EhDPCK2 sense (5’-
CAGAGGCCTATGGTATTTGTTATTGGTATCAC-3’), antisense (5’-
AATGAGCTCTTCTAGTTTCCCAGATAACATTTA-3’). These oligonucleotides contained 
StuI and SacI restriction sites (shown in bold). PCR products were digested with StuI and SacI 
(New England BioLabs, Massachusetts, USA), and ligated into the StuI and SacI double 
digested psAP2-Gunma (Husain et al., 2011) to construct gene silencing plasmids. The 
trophozoites of G3 strain were transformed with the empty vector as a control and silencing 
plasmids by liposome-mediated transfection as previously described (Nozaki et al., 1999). 
Transformants were initially selected in the presence of two μg/ml geneticin with gradually 
increased up to 10 μg/ml. 
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3.3.6. Reverse transcription PCR 
Total RNA was extracted from ~106 trophozoites of EhDPCK1, EhDPCK2 gene silenced 
and control transformant strains using TRIzol (Ambion, Life Technologies) reagent as described 
in the previous study (Chomczynski and Mackey, 1995). DNase treatment was performed using 
DNase I (Invitrogen) to exclude genomic DNA. RNA quantity was determined by measuring the 
absorbance at 260 nm with NanoDrop ND-1000 UV-Vis spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA).  Approximately one μg total RNA was used for cDNA 
synthesis using First-Stand cDNA Synthesis (Superscript® III, Invitrogen) with reverse 
transcriptase and oligo (dT) primers according to manufacturer’s instructions. The cDNA product 
was diluted 10 fold and PCR reactions were carried out in 50 μL, using primer pairs: DPCK1 
sense (5’-ATGAAAAAGATATTTGTTATTGGT-3’), antisense (5’-
TTAAAATTTATTTTCATTGAAGTCAA-3) and DPCK2 sense (5’-
ATGGTATTTGTTATTGGTATC-3), antisense (5’-TTAGTTTAAAGTAATTTTTAATTGTT-
3). 
The PCR conditions were: 98°C, 10 sec; 55°C, 1 min; and 72°C, 1 min; 20-25 cycles. The PCR 
products obtained were resolved by agarose gel electrophoresis. 
3.3.7. Quantitative real-time (qRT) PCR 
Relative levels of mRNA of the EhPanK (EHI_183060), EhDPCK1 and EhDPCK2 
(EHI_040840 and EHI_155780, respectively) were measured using qRT-PCR.  RNA 
polymerase II gene (EHI_056690) was used as a reference. Each 20 µL reaction mixture 
contained 10 µL of 2X Fast SYBR Green Master Mix (Applied Biosystems, Foster City, CA, 
USA), 0.6 µL each of 10 μM  sense and antisense primers, 5 µL 10x diluted cDNA, and 
nuclease free water. PCR was performed using StepOne Plus Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA) with the cycling conditions: enzyme activation at 95oC for 
20 sec, followed by 40 cycles of denaturation at 95oC for 3 sec and annealing-extension at 60oC 
for 30 sec. All reactions were carried out in triplicate, including cDNA-minus controls. The 
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amount of the steady state mRNA of each target gene was determined by the ∆Ct method with 
RNA polymerase II as a reference gene (Livak and Schmittgen, 2001). The mRNA expression 
level of each gene in the transformants was expressed relative to that in the control transfected 
with psAP2. 
3.3.8. Growth kinetics 
Trophozoite cultures were continuously maintained in mid-log phase as described above. 
Glass tubes (6-ml, Pyrex) containing approximately 0.5 x 106 cells were placed on ice for 5 min 
to detach cells from the glass surface.  Centrifugation at 500 ×g for 5 min at room temperature 
was conducted to collect cells. After discarding the spent medium, the pellet was re-suspended in 
1 mL of BI-S-33 medium. Cell densities were estimated on a hemocytometer. Approximately 
10,000 trophozoites were inoculated in 6 mL fresh BI-S-33 medium. Cell density of the cultures 
were estimated on a hemocytometer every 24 h for 5 days. 
3.3.9. Enzymes activity and CoA determination from cell lysates 
Approximately 106 cells cultivated in 25cm2 flasks (Iwaki, Fukushima, Japan) for 48 h 
were harvested and the cell number was estimated as described above. The cell pellet was 
resuspended and homogenized in homogenization buffer (50 mM Tris-HCl, pH 7.5, 250 mM 
sucrose, 50 mM NaCl) supplemented with 1 mM PMSF and 0.5 mg/ml E-64 (Peptide Institute, 
Osaka, Japan) by mechanical homogenization with a glass homogenizer. After kept on ice for 30 
min, the suspension was centrifuged at 500 x g for 30 min at 4°C to remove unbroken cells.  
Enzyme activity in the supernatant was used for enzymatic assay.  
Concentrations of CoA in cell lysates were measured using the CoA assay kit 
(BioVision, CA, USA) according to the manufacturer’s instructions. CoA at 0.05–1 nmole was 
used to produce a standard curve to determine the CoA concentrations in lysates.  Experiments 
were conducted in triplicate, and repeated three times on three different days. 
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3.3.10. Intracellular metabolite extraction 
Intracellular metabolites from 1 x 107 E. histolytica DPCK1 and DPCK2 gene silencing 
cells were extracted according to the previous protocol (Jeelani et al., 2012). Internal standards, 
200 µM of 2-(N-morpholino)-ethanesulfonic acid and methionine sulfone, were added to every 
sample to ensure that experimental artifacts such as ion suppression did not lead to 
misinterpretation of metabolite levels. 
3.3.11. Instrumentation of capillary electrophoresis-mass spectrometry (CE-MS) 
CE-MS was performed as previously described (Kinoshita et al., 2007; Yamamoto et al., 
2014). The instrument used was an Agilent CE Capillary Electrophoresis System equipped with 
an air pressure pump, an Agilent 1100 series isocratic high-performance liquid chromatography 
pump and an Agilent 1100 series MSD mass spectrometer. I also used a G1603A Agilent CE-
MS adapter kit, and a G1607A Agilent CE-MS sprayer kit (Agilent Technologies). G2201AA 
Agilent ChemStation software for CE-MSD was used for system control and data acquisition. 
3.3.12. CE-MS conditions for cationic, anionic compounds, and nucleotides 
Cationic nucleotides compounds were carried out on a gas chromatograph capillary, 
polydimethylsiloxane (DB-1) (50-µm inner diameter x 100-cm total length) (Agilent 
Technologies). CE separation was using 50 mM ammonium acetate, pH 7.5 as the electrolyte. 
Samples solution (~3 nL) was injected at 50 mbar for 30 sec, and a positive voltage of 30 kV 
was applied. All other conditions were the same as in the anionic metabolite analysis. Anionic 
were coated in SMILE (+) capillary 50-µm inner diameter x 100-cm total length obtained from 
Nacalai Tesque (Kyoto, Japan). The electrolyte was 50 mM ammonium acetate solution (pH 
8.5). Sample solution (~30 nL) was injected at 50 mbar for 30 sec and a negative voltage of 30 
kV. The capillary voltage was set at 3.5 kV for ESI-MS in the negative ion mode. Deprotonated 
[M-H] ions were monitored for anionic metabolites of interest. 
59 
 
3.3.13. Statistical analsyisis of metabolomic data and pathway analysis 
For each experimental condition, three independent biological replicates were made and 
for each biological replicate, two technical replicates were made. All data are shown as means ± 
S.E. or the indicated number of experiments. Statistical comparisons were made by Student’s t-
test. Pathway analysis was conducted using Kyoto Encyclopedia of Genes and Genomes 
database (KEGG, https://www.genome.jp/kegg). 
3.3.14. Phylogenetic analyses of E. histolytica  DPCK1 and DPCK2 
By Basic Local Alignment Search Tool Protein (blastp) searches in public sequence 
databases, I collected 88 DPCK sequences including two E. histolytica  sequences  from non-
redundant protein sequences (nr) database of National Center for Biotechnology Information 
(NCBI, http://www.ncbi.nlm.nih.gov/) by using E. histolytica EhDPCK1 sequence 
(EHI_040840/ XP_648971) as a query to obtain data from representative taxa. Hit sequences 
with E-value less than 1 x 10-10 were selected. The number of selected sequences in each blastp 
search for a representative taxon was determined based on the number of listed alignments. 
Sequences were aligned using Muscle program (Edgar, 2004) in SeaView package version 4.6.1 
(Gouy et al., 2010). I selected 112 positions of unambiguously aligned by manual and used for 
phylogenetic analyses. The data matrices for phylogeny were subjected to IQTREE program 
(Nguyen et al., 2015) to select appropriate models for amino acid sequence evolution. LG + I + 
Г4 and LG + Г4 models were shown to be the best and the second-best models by using the 
information criterion. Maximum likelihood (ML) analysis implemented in the RAxML program 
version 7.2.6 (Stamatakis, 2006) was used to infer ML tree. In the bootstrap analysis, heuristic 
tree search was performed with a rapid bootstrap algorithm option (-f) for 100 bootstrap 
replicates. Bootstrap proportion (BP) values greater than 50 were indicated on the corresponding 
internal branches of the ML tree drawn by the use of FigTree program Version 1.4.2 
(http://tree.bio.ed.ac.uk/software/figtree/). 
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3.4. Results 
3.4.1. Identification and features of two DPCK isotypes 
Two genes encoding DPCK were identified from the genome database of E. histolytica 
HM-1:IMSS (HM-1) reference strain (http://amoebadb.org/amoeba/): EHI_040840 and 
EHI_155780, herein designated as EhDPCK1 and EhDPCK2 genes, respectively. The open 
reading frames of the two genes are 621 and 615 bp in length and encode 206- and 204-amino 
acid long proteins with the calculated molecular mass of 23.9 and 23.1 kDa, respectively. The 
two proteins exhibit 38% mutual identity. EhDPCK1 shows 31%, 29%, and 26% percentage 
identity to orthologs from human, Arabidopsis thaliana, and Escherichia coli, whereas 
EhDPCK2 shows 34%, 29% and 28% identity to the orthologs from human, A. thaliana and 
Escherichia coli, respectively. Human, A. thaliana, and E. coli only have one functional copy of 
DPCK and seem to be slightly closer to EhDPCK2 than to EhDPCK1. 
DPCK was reported to consist of five parallel β-strands flanked by α–helices with ATP-
binding site and CoA-binding domain (O’Toole et al., 2003; G Obmolova et al., 2001). 
EhDPCK1 and 2 contain the highly conserved P-loop or Walker A sequence motif 
(GXXXXGKT/S, where X is any residue) which is reported to be involved in nucleotide binding 
(Galina Obmolova et al., 2001). When compared to E. coli DPCK, almost all key residues 
implicated for CoA binding are conserved in both EhDPCK1 and 2 (O’Toole et al., 2003). The 
only exceptions are the substitution of Val473 in human ortholog with Leu114 and Leu117 in 
EhDPCK1 and EhDPCK2, respectively. Gly56 and Gly55 in EhDPCK1 and EhDPCK2, 
respectively, located between helices α3 and α4 are predicted to be important to maintain 
structural integrity.  
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3.4.2. Kinetic parameters, phosphoryl donor specificities, metal dependence, and inhibition 
of EhDPCK1 and EhDPCK2 
EhDPCK1 and EhDPCK2 recombinant enzymes were successfully produced using E. 
coli expression system and purified for enzymological characterization. As demonstrated by 
SDS-PAGE analysis under reducing conditions, followed by Coomassie Brilliant Blue (CBB) 
staining and immunoblot assay, both enzymes were detected in both the soluble and insoluble 
fractions. Purified proteins were obtained with a relatively low yield: typically around 0.3 mg of 
protein purified from a 500 ml E. coli culture (Table 8). The purity of recombinant EhDPCK1 
and 2 was estimated to be 90~95% by densitometric scanning of the CBB stained gels after 
SDS-PAGE (Fig. 16). Immunoblots also indicate only negligible truncated forms of both 
EhDPCK1 and 2 were present in the final preparations. The apparent molecular mass of the 
purified proteins was consistent with the molecular mass of 23.9 and 23.1 kDa for native 
EhDPCK1 and EhDPCK2, respectively, plus 2.6 kDa corresponding to the histidine tag.  
The specific activity of the purified enzymes was estimated as 2.13±0.15 and 2.54±0.26 
µmole/min/mg (mean±S.E. of triplicates) for EhDPCK1 and EhDPCK2, respectively.  
EhDPCK1 and EhDPCK2 showed a broad pH optimum between 7 and 9 with the maximum 
activity at 8 (Fig. 17). No difference was observed in the pH dependency between EhDPCK1 
and EhDPCK2. Kinetic constants for EhDPCK1 and EhDPCK2 were determined by measuring 
the initial rates obtained with different concentrations of ATP and dephospho-CoA (Table 9). 
Both ATP and dephospho-CoA exhibited hyperbolic saturation kinetics when assayed over the 
range of 4-128 μM dephospho-CoA in the presence of 5-100 μM ATP and in the range of 1-100 
μM ATP substrates in the presence of 16-128 μM dephospho-CoA (data not shown). EhDPCK1 
showed the Km values of 114±19 μM and 19.6±1.2 μM for dephospho-CoA and ATP, 
respectively. EhDPCK2 showed lower Km values with 57.9±6 and 15.0±2.4 μM for dephospho-
CoA and ATP, respectively. Neither EhDCPK1 nor 2 utilized pantothenate as a substrate (<0.02 
µmole/min/mg). 
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Recombinant EhDPCK1 and EhDPCK2 could use various nucleoside triphosphates, such 
as ATP, CTP, GTP, and UTP, as phosphoryl donors (Table 10). GTP could partially replace 
ATP for both EhDPCK1 and EhDPK2 (24-33% of the activity relative to that with ATP). 
EhDPCK1 and EhDPCK2 showed slight difference in nucleotide triphosphate preference toward 
TTP. The effects of metal ions were examined by assaying the activity after the addition of metal 
salts to the standard reaction mixture (Table 11). The data also suggest that both EhDPCK1 and 
EhDPCK2 activities are Mg2+-dependent. Furthermore, some cations (Zn2+ and Cu2+) could 
replace Mg2+ with relative activity higher than 50%. No activity was detected when Na+ or K+ 
was used instead of Mg2+. Both EhDPCK1 and EhDPCK2 showed similar profiles of inhibition 
by CoA, acetyl-CoA, and malonyl-CoA at relatively high concentrations (Fig. 18). 
3.4.3. Phenotypes caused by gene silencing of EhDPCK1 and EhDPCK2 
To better understand the role of DPCK in E. histolytica, I created a transformant strain 
where DPCK gene expression was selectively repressed by small antisense RNA-mediated 
transcriptional gene silencing. A 400-bp long region of EhDPCK1 and EhDPCK2 genes that 
corrensponds to the amino-terminal portion of the protein was used to design gene silencing 
constructs. Despite low identity at nucleotide and amino acid levels between the two isotypes, 
gene silencing of EhDPCK1 gene also affect EhDPCK2 gene and vice versa  (Figs. 19 and 20, A 
and B). Gene silencing of EhDPCK1 gene caused 77±1.2 % and 46±18.9% reduction of 
EhDPCK1 and EhDPCK2 transcripts, respectively, while gene silencing of EhDPCK2 gene 
caused 41±14.8% and 88±2.9% reduction of EhDPCK1 and EhDPCK2 transcripts, respectively. 
Interestingly, gene silencing of either EhDPCK1 or EhDPCK2 gene caused upreguation of 
EhPanK transcript (Figs. 19B and 20B), which may indicate compensation for EhDPCK gene 
silencing.  
EhDPCK1 and EhDPCK2 gene silenced (gs) strains showed significant growth defect in 
normal growth medium (Figs. 19C and 20C).  The level of growth inhibition by EhDPCK2 gene 
silencing was more severe compared to that by EhDPCK1 gene silencing; the percentage growth 
63 
 
at 96 h of EhDPCK1 gs and EhDPCK2 gs trophozoites was 53.8±9.2% and 23.1±6.2% 
(mean±S.E. of triplicates) of the control transformant, respectively. Cells lysates from 
EhDPCK1 gs strain contained 24.0±2.0% less DPCK activity (Fig. 19E) and an approximately 
38.9±7.1% lower level of CoA (Fig. 19D). The effects of EhDPCK2 gene silencing on the 
reduction of DPCK activity and CoA concentrations in cell lysates were more severe than those 
by EhDPCK1 gene silencing; 44.0±6.2%  decrease in DPCK2 activity (Fig. 20E) and 61.1±7.1%  
decrease in the CoA concentration by DPCK2 gene silencing (Fig. 20D). Altogether, these 
results suggest that both EhDPCK isotypes play important roles in cell growth and the role 
played by EhDPCK2 is more indispensable than that of EhDPCK1. 
3.4.4. Metabolomic analyses of EhDPCK1 and EhDPCK2 gene silenced strains 
I performed metabolomics analyses of the EhDPCK1 and EhDPCK2 gs strains. The 
capillary electrophoresis-mass spectrometry (CE-MS) based quantitation systems were used both 
in cation and anion modes to identify >110 metabolites which include precursors, intermediates, 
and end products of central carbon metabolism, biosynthetic and catabolic intermediates of 
amino acids, sugars, nucleic acids, and lipids. All data were presented as normalized by cell 
number (per 1 x 106 cells), as commonly accepted and used in many studies. The levels of some 
metabolites were changed in both directions (i.e., increase and decrease) in response to 
EhDPCK1 and EhDPCK2 gene silencing. However, all of the statistically significant changes in 
the concentrations of metabolites in both EhDPCK1 and EhDPCK2 gene silencing were 
decrease, not increase, relative to the metabolite levels in the control strain.   
Besides decrease in the CoA concentration mentioned above, EhDPCK1 gene silencing 
caused decrease only in citrate, ornithine, some nucleic acids, and S-adenosyl-L-methionine (Fig. 
21). On the other hand, EhDPCK2 gene silencing caused decrease in a wider range of 
metabolites than EhDPCK1, such as pantothenate, acetyl-CoA, glutamate, ornithine, putrescine, 
spermidine, methionine, and S-adenosyl-L-methionine, which were mapped to metabolites 
involved in ornithine and polyamine biosynthesis in Kyoto Encyclopedia of Genes and Genomes 
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Database (KEGG) maps (Fig. 22). EhDPCK2 gene silencing also caused decrease in metabolites 
involved in glycogen/glucuronate and chitin metabolism (Fig. 23). Interestingly, most of the 
intermediate metabolites in purine metabolism were also decreased by EhDPCK2 gene silencing 
(Fig. 24). Metabolite changes caused by EhDPCK1 gene silencing in ornithine and polyamine 
biosynthesis, glycogen/glucuronate, chitin, and purine metabolisms were presented in 
supplementary figures (Fig. 25-27). 
3.4.5. Phylogenetic analysis of DPCK 
 Eighty eight DPCK sequences from broad taxonomic groups was obtained, aligned, 
and analyzed. All major groups of Eukaryota possess putative homologs of DPCK. There are 
only few other eukaryotes that possess more than one copy of DPCK homologs (e.g. 
trypanosomes). DPCK gene duplication in E. histolytica apparently occurred before speciation.  
However, I did not perform further searches for duplicated homologs in other eukaryotic species. 
While most of the sequences were well aligned throughout the proteins, three eukaryotic 
homologs (Homo sapiens, Mus musculus, and D. melanogaster) possess an approximately 350 
amino acids long N-terminal extension, which corresponds to phosphopantetheine 
adenylyltransferase domain of the phosphopantetheine adenylyltransferase / DPCK bifunctional 
enzyme. As shown in an alignment of the selected DPCK sequences from representative taxa, 
the amino acid residues involved in the CoA binding (T12, D38, H98, P134, L135, and Q183), 
and in the ATP binding (G13, G14, I15, G18, K19, R163, and N199) well conserved most of 
DPCK sequences were perfectly conserved in Entamoeba homologs.  
Phylogenetic analyses of 88 sequences on the basis of 112 aligned positions inferred an 
optimal Maximum Likelihood (ML) tree shown in Fig. 28. As a whole, DPCK sequences are 
highly divergent suggested by long branches. Consequently, no resolution has been inferred for 
deep branching patterns across all parts of the tree. Neither was inferred the origin of the 
Entamoeba homologs. However, in the genus Entamoeba, all DPCK sequences including two 
isotypic genes for each species (E. histolytica, E. nuttalli, E. dispar, and E. invadens) are 
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monophyletic, although the bootstrap support value was not high (66%). Furthermore, 
monophyly of copy 1 or copy 2 among the four Entamoeba species genes was supported with 
87% and 88% BP values, respectively, suggesting that DPCK gene duplication likely occurred in 
the common ancestor of four Emtamoeba species, followed by speciation of the four species.  
3.4.6. Bioactive screening against EhDPC1 and EhDPCK2 
Since DPCK1 and DPCK2 indicated indispensable for E. histolytica development, I 
propose these two enzymes to be a drug specific target. I developed assay system for rapid cell 
free based screening by EhDPCK1 and EhDPCK2 enzyme target. In this condition, one 
thousand and five hundred microbial extracts were tested against EhDPCK1 and EhDPCK2 and 
show many inhibitors. Resume of the screening results was presented in Table 12.  
 
3.5. Discussion 
3.5.1. Suggested specific roles of EhDPCK isotypes 
My study on E. histolytica PanK in Chapter 2, the enzyme that catalyzes the first step of 
CoA biosynthesis, clearly demonstrated that this enzyme was important for growth of E. 
histolytica trophozoites. In this study, I have shown that both of two DPCKs, EhDPCK1 and 
EhDPCK2, play an indispensable, likely non-overlapping role in CoA biosynthesis.  A line of 
evidence supports that both enzymes are involved in CoA biosynthesis in E. histolytica. First, E. 
coli-produced recombinant enzymes show comparable specific activity and kinetic parameters. 
Second, EhDPCK1 and EhDPCK2 gene silencing caused decrease in DPCK activity and 
intracellular CoA concentrations, as well as decrease in cell growth.  
Most eukaryotic organisms possess a single copy of DPCK gene with some exceptions 
including Trypanosoma (TriTrypDB; http:// http://tritrypdb.org/tritrypdb/) and Entamoeba (this 
study). In a rodent Plasmodium species, which has only one copy of DPCK, it has recently been 
reported that DPCK is essential and indispensable for development of blood stage parasites (Hart 
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et al., 2017). Human infecting Plasmodium species (P. falciparum and P. vivax) also have a 
single copy of DPCK gene.  
In this study, I have shown that Entamoeba, where two copies of DPCK are present, gene 
silencing of EhDPCK2 produced more severe effects on both the metabolite profile and growth, 
compared to that of EhDPCK1. The previous microarray analysis of E. histolytica trophozoites 
showed that the EhDPCK2 transcript level is higher than that of EhDPCK1, approximately 5 
fold in HM-1:IMSS cl6 strain (Penuliar et al., 2015, 2012) and 11 fold in G3 strain (Furukawa et 
al., 2013, 2012; Nakada-Tsukui et al., 2012). Furthermore, based on the previous transcriptomic 
analysis of encystation (differentiation of the trophozoite into the cyst) of E. invadens (De Cádiz 
et al., 2013), which is the amebic encystation model (Chia et al., 2009; Donaldson et al., 1975; 
Kojimoto et al., 2001; Stanley, 2003), I found that both of the E. invadens genes encoding 
DPCK1 and DPCK2 were expressed during encystation. E. invadens DPCK2 gene was 
expressed at comparable levels throughout encystation. In contrast, E. invadens DPCK1 
transcript was dramatically increased (~30-fold) during encystation. These data suggest that 
these isoenzymes play specific roles during proliferation and stage conversion. DPCK1 is likely 
involved in encystation in E. invadens. However, gene silencing of EhDPCK1 and EhDPCK2 
caused comparable, though slightly more pronounced in EhDPCK2 gs strain, growth and 
metabolic defects. My results indicate that EhDPCK2 plays a primary role in the proliferative 
trophozoite stage and EhDPCK1 may have a specific role during developmental stage transition, 
which needs to be examined in the future. 
3.5.2. Uniqueness of Entamoeba DPCK  
Two amebic DPCK isotypes, EhDPCK1 and EhDPCK2, showed comparable specific 
activity and substrate affinity despite only 38% mutual identity. When the Km values of amebic 
DPCKs were compared with the human counterpart, phosphopantetheine adenylyltransferase 
and dephospho-CoA kinase bifunctional enzyme (Aghajanian and Worrall, 2002) from human 
has an approximately 10-fold higher Km value toward dephospho-CoA and a 10-fold lower Km 
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value toward ATP (5.2 μM and 192 μM, respectively). These data indicate significant 
biochemical and structural differences exist between amebic and human DPCK and also suggest 
a possibility of discovering or designing parasite-specific DPCK inhibitors. ATP production in 
E. histolytica relies solely on substrate-level phosphorylation during glycolysis because this 
parasite lacks the enzymes and machineries involved in the Krebs cycle and oxidative 
phosphorylation and thus is unable to produce ATP as efficiently as aerobic organisms 
(McLaughlin and Aley, 1985; Reeves, 1985). It is thus plausible that DPCK from E. histolytica 
is able to have higher affinity to ATP than human counterpart. Moreover, my results suggest that 
both EhDPCK1 and EhDPCK2 activity was regulated biochemically not only by the end 
products of this pathway, CoA, but also its thioesters, acetyl CoA and malonyl-CoA through 
feedback inhibition. 
3.5.3. Domain structures 
DPCK have three-domains: the nucleotide binding, the dephospho-CoA binding, and the 
lid domains (G Obmolova et al., 2001). In E. coli, two prolines (Pro90 and Pro134) are highly 
conserved and predicted to be essential for the lid flexibility. These residues are located between 
the nucleotide binding and dephospho-CoA binding domains. However, these residues are only 
partially conserved in EhDPCK1 (Pro138) and EhDPCK2 (Pro90), indicating that the lid 
flexibility of DPCK  is different between E. histolytica and its bacterial ortholog. A lysine 
residue in the GXXXGKS motif is also one of the conserved motifs of DPCKs among 
organisms, and known to be essential for the binding of ATP. Thr10 for EhDPCK1 and Thr8 for 
EhDPCK2 are probably involved in dephospho-CoA binding, whereas Asp35 in EhDPCK1 and 
Asp33 for EhDPCK2 are involved in activation of the 3’-OH group of the ribose for the attack on 
the β-phosphate of ATP, as previously reported in bacteria (O’Toole et al., 2003; G Obmolova et 
al., 2001). Leu85 in EhDPCK1 and Ile84 in EhDPCK2, both of which are also predicted to be 
localized to the CoA-binding site, are also conserved. Asn91 in EhDPCK1 is replaced with Pro90 
in EhDPCK2; the corresponding residue Pro90 in E.coli is located at a hinge and implicated for 
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the movement of the CoA-binding domain during catalysis, suggesting a potential difference in a 
catalytic process between EhDPCK1 and 2.  
3.5.4. Metabolic disturbance caused by DPCK gene silencing  
Metabolomics analysis has been widely used to complement genomics, transcriptomics, 
and proteomics analyses (Castro-Santos et al., 2015; Dumas, 2012), and to provide a 
comprehensive view on the responses to the environmental changes (Fuhrer and Zamboni, 
2015), a metabolic-responsive profile (Holmes et al., 2008; Husain et al., 2011), and also to 
validate target for drug development (Krug and Müller, 2014; Mastrangelo et al., 2014). As 
expected, DPCK gene silencing (particularly gene silencing targeting EhDPCK2) caused 
decrease in the level of CoA and acetyl-CoA levels. Acetyl-CoA occupies a crucial position in 
metabolisms for all living organisms, and serves as an essential metabolic intermediate, a 
precursor of many anabolic reactions, also a donor of protein acetylation and allosteric 
enzymatic regulator  (Choudhary et al., 2014). My metabolome data have also shown the 
disturbance, mostly decrease, in the broad range of related metabolites, in particular those 
involved in ornithine and polyamine biosynthesis. Ornithine is an important precursor of 
polyamines and essential for proliferation (Bacchi and Yarlett, 1993; Heby et al., 2003; Müller et 
al., 2001; Wallace et al., 2003). Polyamine metabolism was targeted to develop drugs against 
Trypanosoma (Begolo et al., 2014) and Leishmania (Das et al., 2016). In P. falciparum, it has 
been known that many cellular processes, such as DNA replication, transcription and translation 
are polyamine dependent and the cellular levels of polyamines reach their peak during the intra-
erythrocytic development (Assaraf et al., 1987). My metabolomics analysis has shown that 
EhDPCK2 gene silencing significantly reduced the levels of many intermediates in the 
polyamine pathway, while DPCK1 gene silencing showed decrease to a lesser extent (not 
statistically significant). Citrate was significantly decreased by EhDPCK1 gene silencing, which 
was not found in EhDPCK2 gs strain.  Citrate is an important intermediate metabolite derived 
from the condensation of acetyl coenzyme A and oxaloacetate in the Krebs cycle. However, 
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since Krebs cycle is absent in E. histolytica, the role of citrate remains elusive and needs future 
investigation.      
 The levels of metabolites in hexose metabolism were also decreased by EhDPCK2 gene 
silencing. In particular, metabolites involved in the hexosamine-amino acid amide transfer and 
chitin biosynthesis, such as glucosamine 6-phosphate and N-acetyl-D-glucosamine 6-phosphate, 
significantly decreased compared to control (p=0.008). However, it is not well understood how 
glucosamine 6-phosphate was completely deprived by EhDPCK2 gene silencing. The decrease 
in glucosamine 6-phosphates was apparently associated with the decreased level of glutamate in 
EhDPCK2 gs strain, via the reaction converting D-fructose-6-phosphate/L-glutamate and D-
glucosamine-6-phosophate and L-glutamine. On the other hand, the decrease in N-acetyl-D-
glucosamine-6-phosphate was likely caused by the decrease in acetyl-CoA as N-acetyl-D-
glucosamine-6-phosphate is generated from a combination of D-glucosamine-6-phosophate and 
acetyl-CoA. Glucosamine 6-phosphate and N-acetyl-D-glucosamine 6-phosphate are also 
important intermediates for chitin biosynthesis. Chitin is important and present as the major 
component of cell wall in cyst and oocyst stages of many protozoan parasites (Chávez-Munguía 
et al., 2007) including E. histolytica (Arroyo-Begovich and Carabez-Trejo, 1982).  Chitin 
biosynthesis was also proposed as a parasite-specific drug target as it is absent in humans 
(Spindler et al., 1990). Interestingly, reduction in the intermediates in the chitin biosynthetic 
pathway was observed only in EhDPCK2 gs strain, but not in EhDPCK1 gs strain. Although 
statistically insignificant, several metabolites in the pathway were increased in EhDPCK1 gs 
strain: glucose-1-phosphate, glucose-6-phosphate, N-acetyl-D-glucosamine-1-phosphate, and N-
acetyl-D-glucosamine-6-phosphate, suggesting that the roles of EhDPCK1 and 2 in chitin 
metabolism are different. 
Many nucleic acids were also decreased in both EhDPCK1 and EhDPCK2 gs strains. 
This may be explained at least in part by the decrease in polyamine synthesis. Polyamines can 
interact with macromolecules such as nucleic acids and are required during nucleic acids 
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packaging (Ruan et al., 1994). Also, the interaction between polyamines and nucleic acids can 
affect structure and stability of DNA (Gosule and Schellman, 1976; Raspaud et al., 1999; van 
Dam et al., 2002). Moreover, most of the intermediary metabolites in purine metabolism in 
EhDPCK2 gs strain were also reduced. Importantly, these changes were specific to EhDPCK2 
gene silencing. In EhDPCK1 gs strain, several purines and intermediates including adenine, 
guanine, IMP, and ADP, were increased compared to control. Purine metabolism is very 
important for DNA and RNA synthesis, nucleotide-dependent enzyme reactions, as chemical 
energy sources (e.g. ATP, GTP), intracellular second messengers (e.g. cAMP), and switch 
signals (e.g. GDP, GTP) for metabolic and gene regulation (Hyde, 2007). However, a majority 
of parasitic protists including E. histolytica (Lo and Wang, 1985) are incapable of de 
novo synthesis of purines and rely on salvage from the host. Hypoxanthine, guanine, xanthine, 
adenine, and adenosine must be imported from the hosts or media via nucleoside transporters 
described in P. falciparum (Carter et al., 2000), Toxoplasma gondii (De Koning et al., 2003), and 
T. brucei (Sanchez et al., 2002). Interestingly, while most of the above-mentioned purines were 
decreased in EhDPCK2 gs strain, hypoxanthine was most dramatically decreased. 
Hypothanthine is regarded as the key precursor of the other purines. For instance, degradation of 
hypoxanthine by added xanthine oxidase in the culture medium strongly inhibits in vitro growth 
of P. falciparum (Berman et al., 1991). Purine metabolic pathways were proposed as promising 
targets for novel drug development against infections caused by P. falciparum (Cassera et al., 
2011), T. gondii (De Koning et al., 2003), and Mycobacterium tuberculosis (Parker and Long, 
2007). 
3.5.5. Regulation of CoA biosynthesis  
EhDPCK2 gene silencing caused reduction of CoA and also led to decrease in 
pantothenate, which can be explained by either high consumption of pantothenate or decrease in 
pantothenate uptake. Most eukaryotes including E. histolytica are unable to synthesize 
pantothenate and rely on uptake of exogenous pantothenate. my qRT-PCR data indicate that the 
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decreased level of CoA by EhDPCK1 or EhDPCK2 gene silencing led to the increase in steady-
state mRNA level of EhPanK gene encoding the protein that catalyzes conversion of 
pantothenate to 4’-phosphopantothenate. This was also confirmed by the observation that PanK 
activity increased in EhDPCK1 and EhDPCK2 gs strains. Although none of the intermediates, 
4’-phosphopantothenate, 4’-phosphopantothenoyl-L-cysteine, pantetheine 4-phosphate, and 
dephospho-CoA was measured in my metabolomics analysis, it is conceivable that these 
metabolites accumulated intracellularly as a consequence of lack of DPCK and upregulation of 
PanK. These data also reinforce allosteric feedback of EhPanK by the CoA regulatory network 
of CoA biosynthesis, which was demonstrated in Chapter 2. 
3.5.6. EhDPCK1 and EhDPCK2 inhibited by microbial extracts  
Microbial extracts from Fungi and Actinomycetes could inhibit EhDPCK1 and 
EhDPCK2, approximately 2-3% from total extracts. I found some microbial broth extracts 
selectively inhibited one isoenzyme, but most of them inhibited both EhDPCK1 and EhDPCK2. 
I calculated that only 7 extracts solely inhibited EhDPCK1, while 22 extracts solely inhibited 
EhDPCK2 and 33 extracts inhibited both EhDPCK1 and EhDPCK3. There showed that more 
inhibitor obtained from Fungi extract than Actinomycetes. It is suggesting that these enzymes 
can be proposed as a novel anti-amoebiosis target. However, additional experiments need to be 
confirmed, against human DPCK or phosphopantetheine adenylyltransferase and dephospho-
CoA kinase bifunctional enzyme in particular. Extended experiment of in vivo test toward 
animal model was also required to evident my hypotheses. 
Collectively, I have demonstrated that DPCK is the important enzyme involved in CoA 
biosynthesis, polyamine, hexose, and nucleic acid metabolisms in the proliferation of trophozoite 
stage of E. histolytica. In trophozoites, EhDPCK2 plays a predominant role, while an 
encystation-specific role is suggested for EhDPCK1. Notable differences in kinetic parameters 
of DPCK between Entamoeba and its host suggest that amebic DPCK is the rational target for 
the development of anti-amebic agents.  
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3.6. Figures and Tables 
 
 
 
Figure 16. Expression and purification of recombinant EhDPCK1 (A and B) and EhDPCK2 (C 
and D). (A and C) Protein samples of recombinant EhDPCK1 (A) and EhDPCK2 (C) at each 
step of purification were subjected to 15% SDS-PAGE under reducing conditions and then 
stained with Coomassie Brilliant Blue R250. (B and D) Immunoblot analysis of purified 
recombinant EhDPCK1 (B) and EhDPCK2 (D) using anti-His antibody.  
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Figure 17. Optimum pH of the recombinant EhDPCK1 (A) and EhDPCK2 (B). Enzymes 
activities were measured at 37°C at the various pHs indicated in the figure. Assays were 
performed as described in Experimental procedures, with 50 ng of EhDPCK1 or EhDPCK2 
recombinant enzyme, 15 mM HEPES, 20 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 0.02% 
Tween-20, 0.1 mg/mL β−globulins, 100 µM ATP and 200 µM dephospho-CoA at 37ºC. Data 
are shown in mean ± S.D. of three replicates. 
 
 
 
Figure 18. Inhibition of on the EhDPCK1 (A) and EhDPCK2 (B) activities by CoA, acetyl-
CoA, and malonyl-CoA. The assays were carried out three times independently. Data are shown 
in mean ± S.D. 
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Figure 19. DPCK gene expression, cell growth, CoA concentration, and DPCK activity in 
EhDPCK1 gene silenced (gs) strain. (A) RT-PCR of EhDPCK1 gene from cDNA of E. 
histolytica transformants. “psAP2” indicates G3 strain transfected with mock psAP-2-Gunma 
vector, and “DPCK1 gs” indicates GS strain transfected with EhDPCK1 gene silencing plasmid. 
(B) Relative levels of gene transcripts encoding EhPanK, EhDPCK1, and EhDPCK2 involved in 
CoA biosynthesis, estimated by qRT-PCR analysis in psAP2 and EhDPCK1 gs transformants. 
qRT-PCR data were normalized against RNA polymerase II, and are shown in percentage 
relative to the transcript level of each gene in psAP2 control. (C) Growth kinetics of E. 
histolytica transformants in BI-S-33 medium. (D) CoA concentrations in cell lysates.  (E) DPCK 
activity in cell lysates of psAP2 and EhDPCK1 gs transformants. Data shown in mean ± S.E. 
Statistical comparison is made by Student’s t-test (*P<0.05, **P<0.01). 
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Figure 20. DPCK gene expression, cell growth, CoA concentration, and DPCK activity in 
EhDPCK2 gene silenced strain. (A) RT-PCR of EhDPCK1 gene from cDNA of E. histolytica 
transformants. (B) Relative levels of gene transcripts encoding EhPanK, EhDPCK1, and 
EhDPCK2, estimated by qRT-PCR analysis using RNA from psAP2 and EhDPCK2 gs 
transformants. qRT-PCR data were normalized against RNA polymerase II, and are shown in 
percentage relative to the transcript level of each gene in psAP2 control.  (C) Growth kinetic of 
E. histolytica transformants in BI-S-33 medium. (D) CoA concentrations in cell lysates.  (E) 
DPCK activity in cell lysates of psAP2 and EhDPCK2 gs transformants. Labels and 
abbreviations are as in Figure 1. 
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Figure 21. The levels of representative intermediary metabolites affected by EhDPCK1 gene 
silencing. (A) Note decrese in the concentrations of coenzyme A (CoA), acetyl-CoA (AcCoA), 
citrate, ornithine, and S-adenosyl-L-methionine (AdoMet). (B) Depletion of nucleotides. Data 
are shown in mean ± S.D. Statistical comparison is made by Student’s t-test (*P<0.05, 
**P<0.01). 
 
77 
 
Figure 22. Metabolic profiles of amino acids, polyamines, and associated metabolites affected 
by EhDPCK2 gene silencing. Broken lines indicate genes whose encoding enzymes known to 
catalyze the steps are likely absent in the genome. Abbreviations are: ND, not detected; CS, 
citrate synthase; AAAT, amino-acid N-acetyltransferase; AGK, acetylglutamate kinase; 
AGGPR, N-acetyl-L-glutamyl-phosphate reductase; AOA, acetylornithine aminotransferase; 
AOD, acetylornithine deacetylase; ODC, ornithine decarboxylase; ADC, arginine 
decarboxylase; MAT, methionine adenosyltransferase, AdoMet, S-adenosyl-L-methionine; 
dAdoMet, S-adenosylmethioninamine; MAO, monoamine oxidase; AdoMDC, S-
adenosylmethionine decarboxylase; SPDS, spermidine synthase; SPS, spermine synthase. Data 
are shown in mean ± S.D. Statistical comparison is made by Student’s t-test (*P<0.05, 
**P<0.01). 
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Figure 23. Metabolic profiles of hexose phosphates, glycogen metabolism, chitin biosynthesis, 
and associated metabolism affected by EhDPCK2 gene silencing. Abbreviation are: G-1P, 
glucose 1-phosphate; G-6P, glucose 6-phosphate; F-6P, fructose 6-phosphate; GlcN-6P, 
glucosamine 6-phosphate; GlcNAc-6P, N-acetylglucosamine 6-phosphate; GlcNAc-1P, N-acetyl 
glucosamine 1-phosphate; UDP-GlcNAc, UDP-N-acetylglucosamine; GS, glycogen synthase; 
GP, glycogen phosphorylase; UGUT, UTP-glucose-1-phosphate uridyltransferase; PGM, 
phosphoglucomutase; GPI, glucose-6-phosphate isomerase; HK, hexokinase; GFAT, 
glutamine:fructose-6-phosphate aminotransferase; GS, glutamine synthetase; PFOR, pyruvate 
ferredoxin oxidoreductase; GNA, glucosamine-phosphate N-acetyltransferase; PNGM, 
phosphoacetylglucosamine mutase; UAP, UDP-N-acetylgalactosamine diphosphorylase; ChS, 
chitin synthase; CDA, chitin deacetylase.  Data are shown in mean ± S.D. Statistical comparison 
is made by Student’s t-test (*P<0.05, **P<0.01). 
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Figure 24. Metabolic profiles of purine metabolism affected by EhDPCK2 gene silencing. 
Broken lines indicate genes whose encoding enzymes known to catalyze the steps are likely 
absent in the genome. Abbreviations are: PNP, purine nucleoside phosphorylase ; ADA, 
adenosine deaminase; XO, xanthine oxidase; HGPRT, hypoxanthine-guanine 
phosphoribosyltransferase; HGXPRT, hypoxanthine-guanine-xanthine 
phosphoribosyltransferase; IMPDH, inosine 5′-monophosphate dehydrogenase; GMPS, 
guanosine monophosphate synthetase; GK, guanylate kinase ; NDK, nucleoside diphosphate 
kinase; RDPR, ribonucleoside-diphosphate reductase; GC, guanylate cyclase; AdSS, 
adenylosuccinate Synthetase ; ASL, adenylosuccinate lyase ; ADK, adenylate kinase; AC, 
adenylate cyclase. Data are shown in mean ± S.D. Statistical comparison is made by Student’s t-
test (*P<0.05, **P<0.01). 
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Figure 25. Metabolic profiles of amino acids (ornithine, glutamate and methionine), polyamines, 
and associated metabolites affected by EhDPCK1 gene silencing. Broken lines indicate genes 
and their encoded enzymes are likely absent in the genome. Labels and abbreviations are as in 
Figure 4. Data are shown in mean ± S.D. Statistical comparison is made by Student’s t-test 
(*P<0.05). 
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Figure 26. Metabolic profiles of hexose phosphates, glycogen metabolism, chitin biosynthesis, 
and associated metabolism affected by EhDPCK1 gene silencing. Labels and abbreviations are 
as in Figure 5.  Data are shown in mean ± S.D. Statistical comparison is made by Student’s t-test 
(*P<0.05). 
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Figure 27. Metabolic profiles of purine metabolism affected by EhDPCK2 gene silencing. 
Broken lines indicate genes whose encoding enzymes known to catalyze the steps are likely 
absent in the genome. Labels and abbreviations are as in Figure 5.  Data are shown in mean ± 
S.D. Statistical comparison is made by Student’s t-test (*P<0.05). 
  
Entamoeba invadens
Clostridium hiranonis B31
Strigomonas culicis
Chlorobium limicola B9
Hirschia baltica B15
Acytostelium subglobosum
Penicillium roqueforti
Sulfurimonas  autotrophica B18
Chlamydia trachomatis B22
Cucumis sativus
Methylophilus sp. B16
Terrisporobacter  othiniensis B31
Polysphondylium pallidum
Cyanobacterium  aponinum B29
Trypanosoma brucei
Entamoeba nuttalli  
Entamoeba dispar
Salinibacter ruber B8
Corynebacterium sp. B26
Deinococcus  proteolyticus B30
Entamoeba nuttalli  
Entamoeba dispar
Stylonychia lemnae
Drosophila  melanogaster Copy1
Homo sapiens
Nannochloropsis gaditana
Escherichia coli B19
Blastocystis sp.
Lactococcus lactis B31
Enterococcus  faecalis B31
Verrucomicrobia  bacterium B21
Leptotrichia buccalis B12
Fusobacterium  nucleatum B12
Caloramator australicus B31
0.3
Brachyspira  hampsonii B24
Photorhabdus  asymbiotica B19
Desulfurispirillum  indicumgi B4
Desulfobulbus  japonicus B17
Nitrospira bacterium B14
Cellulophaga  lytica B8
Leptospira interrogans B24
Thermodesulfobacterium  commune B33
Dictyostelium discoideum
Saccharomyces cerevisiae
Trichomonas vaginalis
Eggerthella sp. B26
Plasmodium falciparum
Endozoicomonas  numazuensis B19
Acanthamoeba castellanii
Trypanosoma grayi
Bodo saltans
Anabaena cylindrica B29
Listeria  monocytogenes B31
Caenorhabditis elegans
Entamoeba invadens
Angomonas deanei  
Dehalogenimonas  lykanthroporepellens B28
Dehalococcoides  mccartyi B28
Acidobacteria bacterium B1
Geobacter  pickeringii B17
Caldicoprobacter  oshimai B31
Caldisericum exile B3
Gregarina niphandrodes
Caldithrix abyssi B5
Thermotoga profunda B34
Hydrogenobacter  thermophilus B2
Endomicrobium  proavitum B7
Nitrospina sp. B13
Rhodopirellula sallentina B20
Armatimonadetes  bacterium B27
Neisseria mucosa B16
Pseudomonas  aeruginosa B19
9 2
100
8 9
7 1
9 5
100
8 0
5 2
5 6
8 8
9 7
7 6
9 8    Entamoeba histolytica
9 6
8 7
8 8
5 6
6 3
8 7
8 7
9 9
6 8
7 7
8 0
6 7
Anaerobaculum  hydrogeniformans B25
Gracilimonas  tropica B23
Amoebozoa
Alveolata
OpisthokontaMus musculus  
Guillardia theta    Cryptophyta
Ectocarpus siliculosus stramenopiles
Vitrella brassicaformis Alveolata
stramenopiles
Amoebozoa
stramenopiles
Oxytricha trifallax Alveolata
Entamoebidae
(Amoebozoa)
Euglenozoa
Opisthokonta
Drosophila  melanogaster Copy2
Setaria italica B31
Arabidopsis thaliana
Alveolata
Intestinibacter  bartlettii B31
Emiliania huxleyi
Euglenozoa
Alveolata
Parabasalia
archaeon GW2011   Archaea
Campylobacter  concisus B18
Copy1
9 6  Entamoeba histolytica Copy2
Fig. 28. Phylogenetic tree of dephospho-CoA Kinase (DPCK) proteins from E. histolytica and other
organisms. Optimal ML tree inferred by RAxML program with LG +Г4 model was shown from 112 DPCK
positions were used in this analysis.
Viridiplantae
Haptophyceae
Archaea
Copy2
83
84 
 
Table 8. Purification of recombinant E. histolytica dephospho-CoA kinase 1 (EhDPCK1) and 
dephospho-CoA kinase 2 (EhDPCK2). 
Enzymes Purification 
step 
Protein 
concentration 
(mg) 
Activity 
(μmole/min) 
Specific activity 
(μmole/min/mg) 
Yield 
(%) 
Purification 
(fold) 
EhDPCK1 Lysate 2.32 2.09 0.90 100 - 
Eluate  0.36 0.77 2.13 36.7 2.4 
EhDPCK2 Lysate 4.48 3.09 0.69 100 - 
Eluate  0.35 0.89 2.54 28.8 3.7 
 
 
Table 9. Kinetic parameters of E. histolytica dephospho CoA kinase 1 (EhDPCK1) and 
dephospho CoA kinase 2 (EhDPCK2) 
 
Enzyme  Substrate Km 
(μM) 
Vmax 
(μmole/min/mg) 
Kcat 
(min-1) 
Kcat/Km 
(min-1μM-1) 
EhDPCK1 Dephospho CoA 114 ± 19 3.71 ± 0.43 88.9 ± 10.3 0.78 ± 0.04 
 ATP 19.6 ± 1.2 3.54 ± 0.09 84.8 ± 2.4 4.32 ± 0.23 
EhDPCK2 Dephospho CoA 57.9 ± 6.07 2.48 ± 0.15 57.5 ± 3.5 0.99 ± 0.07 
 ATP 15.0 ± 2.4 2.71 ± 0.17 62.9 ± 3.7 4.25 ± 0.74 
a Assays were performed in the presence 10 mM MgCl2, 15 mM HEPES, 20 mM NaCl, 1 mM EGTA, 
0.02% Tween-20, 0.1 mg/ml β−globulins and 4-256 µM dephospho-CoA to determine kinetic parameters 
toward ATP or 5-100 µM ATP to determine kinetic parameters toward dephospho-CoA. Reactions were 
conducted at 37oC at pH 8 for 60 min. 
Mean±S.E. of three replicates are shown. 
 
Table 10. Phosphoryl donor specificitya of EhDPCK1 and EhDPCK2 
Phosphoryl donorb Relative activity (%) 
EhDPCK1 EhDPCK2 
ATP 100.0 ± 0.0 100.0 ± 0.0 
TTP   24.1 ± 2.2     4.9 ± 1.1 
GTP   32.6 ± 2.6   33.0 ± 3.8 
CTP   15.4 ± 1.8     7.3 ± 1.6 
UTP     2.6 ± 0.1     4.5 ± 0.3 
None             ND             ND 
a Assays were performed in the presence 10 mM MgCl2, 15 mM HEPES, 20 mM NaCl, 1 mM EGTA, 
0.02% Tween-20, 0.1 mg/ml β−globulins and 1 mM dephospho-CoA. Reactions were conducted at 37oC 
in pH 8 for 60 min. 
b The final concentration used was 0.1 mM.  
The activity is shown in percentage (%) relative to that toward ATP. ND, not detected. 
Mean±S.E. of three replicates are shown. 
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Table 11. Effect of metal ionsa on the activity of EhDPCK1 and EhDPCK2. 
Metalb Relative activity (%) 
EhDPCK1 EhDPCK2 
MgCl2 100.0 ± 0.0 100.0 ± 0.0 
FeCl2   20.9 ± 1.8   12.1 ± 2.7 
CaCl2   10.5 ± 1.7     1.0 ± 0.5 
CoCl2   28.3 ± 6.2   40.9 ± 0.2 
MnCl2   43.8 ± 2.2   53.7 ± 3.1 
ZnCl2   76.9 ± 0.3   78.3 ± 0.1 
NiCl2   45.2 ± 0.3   23.0 ± 2.2 
CuCl2   53.2 ± 5.1   61.5 ± 5.1 
LiCl2     4.9 ± 0.2   21.7 ± 1.5 
NaCl           ND ND 
KCl           ND ND 
None           ND ND 
a Assays were performed in the presence 0.1 mM ATP, 15 mM HEPES, 20 mM NaCl, 1 mM EGTA, 
0.02% Tween-20, 0.1 mg/ml β−globulins and 1 mM dephospho-CoA. Reactions were conducted at 37oC 
in pH 8 for 60 min. 
b The cation final concentration used was 5 mM.  
The activity is shown in percentage (%) relative to that toward MgCl2. ND, not detected. 
Mean±S.E. of three replicates are shown. 
 
 
Table 12. EhDPCK1 and EhDPCK2 inhibitor from microbial extracts 
Origin Number of 
samples 
EhDPCK1* EhDPCK2* EhDPCK1 and 
EhDPCK2* 
Fungi    600 31 32 27 
Actinomycetes    900   9 23   6 
Total 1,500 40 55 33 
  2.6 % 3.6 % 2.2 % 
*inhibited >50% 
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Chapter 4. General Discussion 
 
My experiment showed that pantothenate kinase, dephospho-CoA kinase 1 and 
dephospho-CoA kinase 2 are enzymes involved in CoA biosynthesis pathway in the human 
parasite E. histolytica. Interestingly, these enzymes also showed important or essential to this 
parasite during trophozoite stage, since gene silencing of PanK, DPCK1, and DPCK2 caused 
significant retardation in growth, CoA concentration and related enzymes activity (PanK and 
DPCK enzyme). Metabolomics analyses towards these silencing gene strains also supported the 
importance of these enzymes by disturbance, mostly decreased, of some key metabolites. 
Metabolomics analyses revealed of our understanding regarding the independent role of 
PanK, DPCK1, and DPCK2 in the cellular mechanism. PanK gene silencing caused significant 
changes in metabolites such as overall increase in the majority of upstream (down to pyruvate) 
intermediates of glycolysis and the pentose phosphate pathway, and a decrease in acetyl CoA, 
xanthine, hypoxanthine, ATP, cyclic nucleotides, ornithine, and S-adenosyl-L-methionine. 
EhDPCK1 gene silencing caused the depletion of ornithine, S-adenosyl-L-methionine, some 
cyclic nucleoside monophosphates, and citrate.  On the other hand, suppression of EhDPCK2 
gene affected to the decreasing in the level of acetyl-CoA, and metabolites involved in amino 
acid, glycogen, hexosamine, nucleic acid metabolisms, chitin and polyamine biosynthesis. In 
general, EhDPCK2 affected more severe of metabolite changes compared to EhDPCK1 gene 
silencing. My data indicated both DPCK isotypes play a crucial role in cell cellular reaction, 
whereas EhDPCK2 is more indispensable.  
 According to their essentiality, I proposed PanK, DPCK1, and DPCK2 as potential novel 
drugs target against amebiasis. Therefore, I produced recombinant of EhPanK, EhDPCK1, and 
EhDPCK2 in E. coli expression system and characterized it. Biochemically characterization of 
these enzymes (e.g. determination of Km, Vmax, phosphoryl donor specificity, effect of various 
metal ions to the enzyme activity, regulation by the end product, CoA, and its thioester) 
combined with phylogenetic analyses showed some uniqueness compared to human counterpart 
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enzymes, suggesting a possibility to discovering or designing entamoeba-specific PanK or 
DPCK inhibitors. Using these enzymes, cell free-based screening system has been developed. 
Initially, 244 natural compounds and 3,000 microbial extracts from fungi and actinomycetes 
were screened against EhPanK and 1,500 microbial extracts were screened against EhDPCK1 
and EhDPCK2 recombinant enzyme. 
In conclusion, I have shown that pantothenate kinase and dephospho-CoA kinase 
involved in CoA biosynthesis are physiologically important for this parasite. Some potential 
EhPanK inhibitors were identified from natural product library. For extracts screening, potential 
microbial extracts that inhibited EhPanK, specific inhibited EhDPCK1 and EhDPCK2 or 
inhibited both EhDPCK1 and EhDPCK2 have been found. However, further purification and 
compound identification from some hit extracts still in progress so that not described in this 
report.  Collectively, my study suggesting that EhPanK, EhDPCK1, and EhDPCK2 are enzymes 
can be a new target for the development of anti-amebic drugs.   
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